<PAGE>   1

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C.  20549

                                 FORM 10-K/A

             [X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
            THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED,
                          EFFECTIVE OCTOBER 7, 1996]
                  For the Fiscal Year Ended December 31, 1996
                                       OR
           [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                      THE SECURITIES EXCHANGE ACT OF 1934

                         Commission file number 0-19147

                              Coventry Corporation
             (Exact name of registrant as specified in its charter)

            Tennessee                                       62-1297579
 (State or other jurisdiction of                         (I.R.S. Employer
  incorporation or organization)                       Identification Number)
                                                      
 53 Century Boulevard, Suite 250                      
 Nashville, Tennessee                                          37214
 (Address of principal executive offices)                    (Zip Code)

      Registrant's telephone number, including area code:  (615) 391-2440

Securities registered pursuant to Section 12(b) of the Act:  None

Securities registered pursuant to Section 12(g) of the Act:  Common Stock, $.01
par value

      Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES X NO

      Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K.  [ ]

      The aggregate market value of the registrant's voting Common Stock
held by non-affiliates of the registrant as of March 14, 1997 (computed by
reference to the closing price of such stock on The Nasdaq Stock Market) was
$375,543,737.

      As of March 14, 1997, there were 33,014,834 shares of the registrant's
voting Common Stock outstanding.

<PAGE>   2




                            COVENTRY CORPORATION

                                 FORM 10-K/A

                               TABLE OF CONTENTS

<TABLE>
<CAPTION>
                 PART I                                                                                 Page
                                                                                                        ----
<S>              <C>                                                                                     <C>
Item 1:          Business                                                                                 1

Item 2:          Description of Property                                                                  9

Item 3:          Legal Proceedings                                                                       10

Item 4:          Submission of Matters to a Vote of Security Holders                                     10

PART II

Item 5:          Market for Registrant's Common Equity and Related Stockholder Matters                   11

Item 6:          Selected Consolidated Financial Data                                                    12

Item 7:          Management's Discussion and Analysis of Financial Condition and Results of Operations   14

Item 8:          Financial Statements and Supplementary Data                                             24

Item 9:          Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    45

PART III

Item 10:         Directors and Executive Officers of the Registrant                                      46

Item 11:         Executive Compensation                                                                  49

Item 12:         Security Ownership of Certain Beneficial Owners and Management                          55

Item 13:         Certain Relationships and Related Transactions                                          56

PART IV

Item 14:         Exhibits, Financial Statement Schedules and Reports on Form 8-K                         57
                                                                                
</TABLE>
<PAGE>   3




                                     PART I

ITEM 1:  Business


(a)  General Development of the Business

         Coventry Corporation ("the Company") is a managed health care company
that provides comprehensive health benefits and services to 894,076 members in
Pennsylvania, Ohio, West Virginia, Missouri, Illinois, Virginia and Florida at
December 31, 1996.  Health care services are provided to employer groups and
government funded groups through a variety of full-risk health care plans,
including health maintenance organization and preferred provider organization
products. Additionally, the Company administers self-insured health plans of
certain large employers.  The Company's enrollment increased to 901,891 in
January 1997.

         The Company's regional operations are based in Pittsburgh (western
Pennsylvania, eastern Ohio and West Virginia), and Harrisburg (central
Pennsylvania), (collectively, the "Pennsylvania Health Plans"), St. Louis,
Missouri ("the St. Louis Health Plan"), Richmond, Virginia (the "Richmond
Health Plan") and Jacksonville, Florida.

         The Company was incorporated in 1986 in Delaware.  Its principal
executive offices are located at 53 Century Boulevard, Suite 250, Nashville,
Tennessee 37214, and its telephone number is (615) 391-2440.  Unless the
context indicates otherwise, references herein to "Coventry" and "the Company"
include Coventry Corporation and its subsidiaries.


(b)  Financial Information about Industry Segments

         The Company operates only in the managed care industry, and
accordingly, industry segment data is not applicable.


(c)  Narrative Description of Business

Products

Commercial Health Maintenance Organizations

         The Company's health maintenance organization ("HMO") products provide
comprehensive health care benefits to enrollees, including ambulatory and
inpatient physician services, hospitalization, pharmacy, dental, optical,
mental health, ancillary diagnostic and therapeutic services.  In general, a
fixed monthly enrollment fee covers all HMO services, although some benefit
plans require co-payments or deductibles in addition to the basic enrollee
premium.  A primary care physician assumes overall responsibility for the care
of an enrollee, including preventive and routine medical care and referrals to
specialists and consulting physicians.  While an HMO enrollee's choice of
providers is limited to those within the health plan's HMO network, the HMO
enrollee is typically entitled to coverage of a broader range of healthcare
services than are covered by typical reimbursement or indemnity policies.  At
December 31, 1996, the Company had approximately 416,000 commercial HMO
members.

         The Pennsylvania Health Plans have licensed HMO service areas in
Pittsburgh and eight surrounding counties in western Pennsylvania, 21 counties
in central Pennsylvania, including the cities of Harrisburg, York, Lancaster,
State College, Lebanon and Scranton and five counties in eastern Ohio.  Through
Coventry Health Plan of West Virginia, the Company serves Wheeling and 14
counties in West Virginia.  The St. Louis Health Plan's service area includes
St. Louis and 23 adjacent counties in Missouri and 23 counties in central and
southern Illinois.  The Richmond Health Plan services Richmond, Roanoke and 38
counties in central and southwestern Virginia. All of the commercial HMOs are
federally qualified. 


                                      1
<PAGE>   4




Preferred Provider Organizations and Point of Service

         The Company, through its regional health plans, also offers
fully-insured flexible provider products, including preferred provider
organization ("PPO") and point of service ("POS") products, which permit
enrollees to participate in managed care but allow them to choose, at the time
services are required, to use providers not participating in the managed care
network.  Deductibles and co-payments generally increase the out-of-pocket
costs to the enrollee if a non-participating provider is utilized.  Fully
insured PPO/POS premiums are typically lower than HMO premiums due to these
increased out-of-pocket costs borne by enrollees.  The Company's PPO and POS
products are underwritten by Coventry Health and Life Insurance Company
("CHLIC") a Texas insurance company.  PPO/POS products are currently offered by
the western Pennsylvania, central Pennsylvania, St. Louis, and Richmond health
plans.  At December 31, 1996, approximately 176,000 Coventry members were
enrolled in a flexible provider product.

Medicare

         In late 1995, the Company introduced a Medicare risk product under the
name "Advantra" (R) in the St. Louis market.  In 1996 the Company began
marketing this product in its western Pennsylvania and central Pennsylvania 
markets.

         Under a Medicare risk contract, the Company receives a fixed premium
per member, which reflects certain demographics of the Medicare population of
each region.  At December 31, 1996, there were approximately 1.3 million
Medicare eligibles in the Company's current service areas.  The Company
believes that the Medicare risk product represents substantial opportunity for
enrollment growth.  However, the product also carries the risk of higher
utilization and related medical costs than commercial products, and the
possibility of regulatory or legislative changes which may reduce premiums or
increase mandated benefits in the future.  The Company is also subject to
increased government regulation and reporting requirements related to the
product.

         The Company also offers Medicare cost and supplement products.  Under
a Medicare cost contract, the Company is reimbursed by the U.S. Health Care
Finance Administration ("HCFA") only for the cost of services rendered to
the plan members, including services provided at the health plan's medical
offices and a portion of administrative expenses. HCFA periodically audits the
cost of services and as a result the Company is at risk for less than full
reimbursement. Medicare supplement members enroll individually and pay a
monthly premium for comprehensive health services not covered under Medicare. 
A majority of the Company's former Medicare cost and supplement members
converted to the Company's Advantra product during 1996.  At December 31, 1996
the Company had approximately 28,000 Medicare members, including both risk and
cost based members.

Medicaid

         The Company offers health care coverage to Medicaid recipients in the
north Florida, St. Louis and central Missouri, Richmond, Virginia,
Pittsburgh and central Pennsylvania markets. The Company's Medicaid products in
each region are generally similar to, and based upon, the products offered by
its HealthCare USA, Inc. ("HCUSA") subsidiary in Jacksonville, Florida, and
HCUSA generally administers the Company's Medicaid products in each of the
other regions.  Medicaid recipients in north Florida, St. Louis and central
Missouri markets are generally required to choose a managed care provider.  In
Pittsburgh, central Pennsylvania and Richmond, Virginia, enrollment in a
Medicaid HMO is voluntary.  Under a Medicaid risk contract, the participating
state pays a monthly premium based on the age and sex of the recipients
enrolled in the Company's plans. 



                                      2
<PAGE>   5
        Like the Medicare risk product, the Medicaid product makes the 
Company's financial results more susceptible to government regulation and
legislative changes in premium levels and benefit structure. Under current
regulations, HMOs offering Medicaid products on a mandatory enrollment basis
must within certain time frames broaden their membership to include at least
25% commercial HMO members. The Company's Florida HMO has not achieved this
required percentage of commercial membership in Florida, but has received a 
waiver of this requirement through June, 1998. Premium rates paid to the
Company's Medicaid operations in Florida were significantly reduced in 1995,
and future funding levels cannot be predicted with certainty.  As a result of
premium rate reductions and the commercial membership requirements, the Company
has determined that its Florida Medicaid operations are unlikely to be
sufficiently profitable on a long-term basis to justify a continued presence in
the Florida market and, as a result, the Company is considering various options
concerning this business, with the long-term goal of exiting the Florida
Medicaid market.  Accordingly, the Company has established a reserve of $1.2
million at December 31, 1996 to reflect the anticipated costs of exiting this
market. The Company believes that its existing commercial membership in its St.
Louis Health Plan will satisfy the regulatory commercial membership  
requirements in Missouri.  At December 31, 1996, approximately 122,000 Coventry
members were enrolled in a Medicaid risk product, including approximately
28,000 in Florida, 77,000 in Missouri and 17,000 in other regions.  See
"Government Regulations."

Administrative Services Only

         The Company's health plans offer an administrative services only
("ASO") product to large employers who self-insure their employee health
benefits.  Under the ASO contracts, employers who fund their own health plans
receive the benefit of provider pricing arrangements from the health plan and
the health plan also provides a variety of administrative services such as
claims processing, utilization review and quality assurance for the employers.
The health plan receives an administrative fee for these services but does not
assume the health care cost underwriting risk.  Certain of the Company's ASO
contracts include performance and utilization management standards which affect
the fees received for these services.  Approximately 153,000 of the Company's
members were ASO members at December 31, 1996.


Delivery Systems

         The health plans maintain provider networks which furnish health care
services through direct employment of or contractual arrangements with
physicians, hospitals and other health care providers, rather than providing
reimbursement to the enrollee for the charges of such providers.  Because the
health plans receive the same amount of revenue from their enrollees
irrespective of the cost of health care services provided, they must manage
both the utilization of services and the unit cost of the services.

         The Company's health plans' networks utilize a variety of physician
care delivery systems which differ primarily in the characterization of the
relationship between the Company and the participating physicians. The Company
utilizes staff models in western and central Pennsylvania and St. Louis,
Missouri to deliver primary care and certain specialist services through
physicians who are employed exclusively by the health plan.  The exclusive
full-time employment of physicians in a staff model generally enables the
health plan to predict costs more effectively, maintain quality and respond
quickly to consumer issues.  However, staff model operations also involves
substantial investment in certain costs, such as facilities and personnel, that
cannot be immediately adjusted to take into account changes in the membership
or third party provider pricing trends. During 1996, the Company initiated
efforts to reduce overhead in its staff models by reducing staff employment and
capitating certain specialist and ancillary functions. In addition to providing
health care to plan members, these staff models also accept non-member patients
on a fee-for-service basis, in an effort to help cover the costs associated
with the medical offices. The Company employed approximately 200 physicians at
December 31, 1996 in its staff model operations.

         The Company's staff model operations, in recent years, have suffered
from over-capacity, and the Company has not been able to increase the number of
members or other patients utilizing such operations sufficiently to make such
operations profitable.  As a result, the Company determined in late 1996 to
seek to dispose of the staff model operations in Pittsburgh, Pennsylvania and
St. Louis, Missouri. In March 1997, the Company entered into agreements to sell
its medical offices associated with its health plan in St. Louis, Missouri to
BJC Health Systems ("BJC"), a major provider organization in the St. Louis
market, and to sell its medical offices associated with its health plan in
Pittsburgh, Pennsylvania to Allegheny Health, Education and Research Foundation
("AHERF"), a major provider organization in the Pittsburgh market.  The 
agreements are subject to the satisfaction of various conditions, including 
regulatory approval.  After these sales, the Company's medical operations will 
be limited to employing 22 physicians in eight offices in the central 
Pennsylvania area.


                                      3
<PAGE>   6



         Coincident with the sale of the St. Louis and Pittsburgh medical 
offices, the Company will enter into long-term global capitation arrangements
with BJC and AHERF, pursuant to which these provider organizations will receive
a fixed percentage of premiums to cover all the medical treatment the Company's
globally capitated members receive from the health care systems.  These
arrangements are a continuation of the Company's efforts to enter into
capitation agreements with major providers whereby the providers will provide
all medical treatment for the Company's members in return for a fixed
percentage of premium.  While these agreements limit the Company's exposure to
the risk of increasing medical costs, they expose the Company to risk as to the
adequacy of the financial and medical care resources of the provider
organization.

         All of the Company's health plans also offer an open panel delivery
system. In an open panel structure, individual physicians or physician groups
contract with the health plans to provide services to enrollees but also
maintain independent practices in which they provide services to individuals
who are not Coventry health plan enrollees.  The Company contracts with
approximately 18,000 physicians through the open panel model.  Additionally,
the Company is aware that entering into global capitation contracts with
certain providers may cause disruption in its existing provider network.


Health Care Provider Compensation

         The primary care physicians employed within the staff model 
operations are compensated under salary and bonus arrangements.  Under
most open panel contracts, each primary care physician is paid a monthly fixed
capitation fee for each enrollee selecting the physician and may receive
additional compensation from risk-sharing arrangements with the health plan to
the extent that pre-established utilization and quality goals are achieved. 
Contracting specialist physicians are compensated under both discounted
fee-for-service arrangements and capitation arrangements.  The majority of the
Company's contracts with hospitals provide for inpatient per diem or per case
hospital rates, while outpatient services are typically contracted on a
discounted fee-for-service basis.  During 1996, the Company converted many of
its hospital and ancillary contracts from discounted fee-for-service to fixed
fee schedules or capitation arrangements.


Quality Assurance

         The Company has established systems to monitor the availability,
appropriateness and effectiveness of the patient care it provides. Monitoring
the number of physicians and support personnel needed for the number of
enrollees served assists in maintaining the availability of care at appropriate
levels. Utilization data collected and disseminated in the context of
controlling costs are also a valuable indicator of over or under utilization of
necessary services and helps the Company's health plans provide optimal care to
their enrollees.

         The Company's health plans also have internal quality assurance review
committees made up of physicians and other staff members whose responsibilities
include periodic review of medical records, development and implementation of
standards of care based on current medical literature and the collection of
data relating to results of treatment.  Studies are regularly conducted to
discover possible adverse medical outcomes for both quality and risk management
purposes.

         Appointment availability, member waiting times and environments are
monitored.  A membership services department is responsible for ensuring
enrollee satisfaction, and the Company's health plans periodically conduct
membership surveys of both existing and former enrollees concerning services
furnished and suggestions for improvement.

         The National Committee for Quality Assurance ("NCQA") is an
independent, nonprofit institution that evaluates and accredits the quality
assurance programs of managed care organizations and is recognized as the
national authority on quality.  Both the Pennsylvania plans have earned full
accreditation. The Richmond and St. Louis plans received provisional
accreditation in 1995 and 1996, respectively.

         In 1996, HCUSA met or exceeded all state standards in a Florida
Medicaid Contract compliance review conducted by the Florida Agency for
Healthcare Administration of 21 Medicaid HMOs.  The Plan scored 100%, the
highest rating received, on the quality of care standards specified in its 1996
Medicaid contract and a 98% overall rating. See "Medicaid" and "Government 
Regulation."


                                      4
<PAGE>   7




Utilization Management and Review

         A managed care company's profitability is dependent on maintaining
effective controls over utilization of health care services consistent with the
provision of high quality care. Each of the Company's health plans employs
physicians as Medical Directors who oversee the delivery of medical services
with respect to staff model and open panel operations.  The Medical Director
supervises medical managers (physicians and nurses) who review and approve the
primary care physicians' referrals to specialists and hospitals.  Medical
managers also continually review the status of hospitalized patients and
compare their medical progress with established clinical criteria.  In
addition, nurses make hospital rounds to review patients' medical progress and
perform quality assurance and utilization functions.

         Medical managers also monitor the utilization of diagnostic services
and encourage use of outpatient surgery and testing where appropriate.  Data
showing each physician's utilization profile for diagnostic tests, specialty
referrals and hospitalization are collected by each health plan and provided to
the health plan's physicians.  These results are monitored by medical managers 
in an attempt to ensure the use of cost-effective, medically appropriate 
services.


Marketing 

         The Company's commercial health plans are marketed primarily to
employer groups as alternatives to conventional fee-for-service health care and
indemnity health insurance programs.  Employers generally pay all or part of
their employees' health care premiums, and many continue to offer their
employees a conventional insurance plan even if one or more of the Company's
products are offered.

         Commercial marketing is generally a two-step process in which
presentations are made first to employers and then directly to employees.  Once
selected by an employer, the Company solicits enrollees from the employee base
directly. During periodic "open enrollments", in which employees are permitted
to change health care programs, the Company uses direct mail, worksite
presentations, and radio and television advertisements to contact new
enrollees.  The Company also markets through independent insurance brokers and
agents. Virtually all of the Company's employer group contracts are renewable 
annually, and enrollment is continuously affected by employee turnover within 
employer groups.

         The Company's Medicaid products are marketed directly to individuals
while its Medicare products are marketed to both individuals, and, primarily in
the Pittsburgh market, employer group retirees. Individual marketing to
Medicare beneficiaries is conducted through use of a direct sales force and
advertising efforts that include television, radio, newspaper, billboards, and
direct mail. The Company also markets through independent insurance brokers and
agents.  The Company's Medicaid and Medicare contracts are renewable annually,
and Medicare and Medicaid enrollees may disenroll monthly.

         Each of the Company's health plans employs a full-time marketing
staff, totaling approximately 200 for the entire company.  Each marketing
staff uses advertising and promotional material prepared by advertising firms
as well as market research programs.

         No single employer group accounted for 10% or more of the Company's
consolidated revenues in 1996.  As of December 31, 1996, the employer groups
which accounted for the ten highest amounts of managed care premiums for the
western and central Pennsylvania, St. Louis and Richmond health plans
represented approximately 26%, 28%, 28% and 62%, respectively, of each health
plan's premiums.  HCUSA received approximately $32.0 million or 27% of its
revenue from the State of Florida and approximately $85.7 million or 73% from
the State of Missouri.


                                      5
<PAGE>   8


Competition

         As of December 31, 1996, the Company estimates that its share of the 
commercial HMO market was approximately 50% in western Pennsylvania, 30% in
central Pennsylvania, 26% in St. Louis, and 24% in Richmond.

         The Company's health plans operate in highly competitive environments
and compete with other HMOs, PPOs, indemnity insurance carriers and, most
recently, physician-hospital organizations.  During 1996 the Company continued
to experience competitive pressures in its commercial products, most notably in
the Pennsylvania and Missouri markets, which adversely affected the premiums
that the Company has historically received from new and existing members, the
membership growth opportunities, and the mix of products sold.  In some cases,
employer groups have moved from the traditional commercial HMO plans toward the
lower premium flexible provider products.

         The Company believes that the principal factors influencing an
employer group's decision to choose among health care options are the price of
the benefit plans offered, locations of the health care providers, their
reputation for quality care, financial stability, comprehensiveness of
coverage, and diversity of product offerings.

         The Company also competes with other managed care organizations and
indemnity insurance carriers in seeking to obtain and retain favorable
contracts with hospitals and other providers of services to the Company's
health plans.  While the Company believes that the relatively large membership
in its health plans places them in a favorable position in negotiating
contracts, some of its competitors represent an equal or greater number of
potential patients for such contracting providers and therefore may be in an
equal or more favorable position to negotiate provider contracts.


Government Regulation

         The Company's commercial HMOs are qualified under the federal Health
Maintenance Organization Act of 1973, which was enacted to promote the
development of HMOs.  Only HMOs that continue to meet federal criteria for
sound fiscal operation may retain their qualified status.  In order to maintain
such qualification, HMOs are required to set enrollment fees, or premiums,
pursuant to a "community rating system", which permits rating by class and
group specific rating on a prospective basis.  The system can place an HMO at a
disadvantage when competing with conventional insurers for the business of
large employers; at the same time, it does not permit an established customer
to demand rate reductions based upon its group's favorable medical experience.

         The Company's HMOs are required to file periodic reports with, and are
subject to periodic review by state and federal licensing authorities that
regulate them.  The HMOs are required by state law to meet certain minimum
capital and deposit and/or reserve requirements and may be restricted from
paying dividends under certain circumstances.  They are also required to
provide their enrollees with certain basic services based substantially on a
fixed, prepaid fee basis.  Even under community rating, however, an HMO may
vary the type of non-fixed benefits offered.  The HMOs are required to have
quality assurance and education programs for their professionals and enrollees.
State laws further require that representatives of the HMOs' enrollees have a
voice in policy making.

         In 1996, HCFA promulgated regulations ("physician incentive
regulations") enforcing Sections 4204(a) and 4731 of the Omnibus Budget
Reconciliation Act of 1990 ("OBRA 90").  OBRA 90 and the physician incentive
regulations prohibit HMOs with Medicare risk contracts from knowingly making
incentive payments to physicians as an inducement to reduce or limit medically
necessary services to Medicare beneficiaries. Under the physician incentive
regulations, HMOs must, among other things, disclose to HCFA their physician
compensation plan in such detail as to allow HCFA to determine compliance with
the regulations, and provide assurance that stop-loss insurance is in place, if
the HMO places a physician or physician group at "substantial financial risk"
for services provided to Medicare beneficiaries. These regulations took effect
beginning January 1997.

         On August 20, 1996, President Clinton signed into law the "Health
Insurance Portability and Accountability Act of 1996," which took effect
beginning January 1997. This legislation requires guaranteed issuance and
renewability of certain health coverage for individuals and small groups,
limits preexisting condition exclusions and provides for a demonstration
project for medical savings accounts.  In addition, more recent federal
legislation, which will become effective beginning January 1998, requires
health plans to provide parity for mental health benefits and at least 48 hours
inpatient coverage for mothers and their newborns.


                                      6
<PAGE>   9
         All of the Company's Medicare and Medicaid plans are subject to HCFA
and state regulations.  HCFA and the appropriate state agencies have the right
to audit any health plan operating under a Medicare or Medicaid contract to
determine the plan's compliance with HCFA and state regulations and quality of
care being rendered to the plan's members.  Because the Company has Medicare
and Medicaid products, it also must comply with requirements established by
peer review organizations ("PRO"s), which are organizations under contract with
HCFA to monitor the quality of health care received by Medicare and Medicaid
beneficiaries.  PRO requirements relate to quality assurance and utilization
review procedures.  In addition, cost reimbursement reports are required with
respect to Medicare cost contracts and are subject to audit and revision.

         The anti-kickback provisions of the Medicare and Medicaid laws
prohibit the payment or receipt of any remuneration in return for the referral
of a patient, the charges for which are subject to reimbursement by Medicare or
Medicaid.  The Department of Health and Human Services has adopted safe harbor
regulations whereby, (i) HMOs' waivers of Medicare and Medicaid beneficiaries'
obligation to pay cost-sharing amounts or to provide other incentives in order
to attract Medicare and Medicaid enrollees and (ii) discounts offered to
prepaid health plans by contracting providers are not deemed to be violations
of the anti-kickback provisions.  The Company believes that the incentives
offered by its HMOs to Medicare and Medicaid beneficiaries and the discounts
its plans receive from contracting health care providers satisfy the
requirements of the safe harbor regulations and do not in any event violate the
anti-kickback provisions.

         The Company is subject to both federal and state regulations regarding
services to be provided to Medicaid enrollees, payment for those services and
other aspects of the Medicaid program.

         The Company contracts with the United States Office of Personnel
Management ("OPM") to provide managed health care services under the Federal
Employees Health Benefits Program ("FEHBP").  These contracts with OPM and
applicable government regulations establish premium rating requirements for the
FEHBP.  OPM conducts periodic audits of its contractors to, among other things,
verify that the premiums established under the OPM contracts are established in
compliance with the community rating and other requirements under FEHBP.
During 1996, managed care premiums were reduced by $1.7 million for the
settlement of OPM claims for 1995 and reserves for 1996 were established.

         Numerous health care proposals have been introduced in the U.S.
Congress and in state legislatures.  These include provisions which place
limitations on premium levels, increase minimum capital and reserves and other
financial viability requirements, prohibit or limit capitated arrangements or
provider financial incentives, mandate benefits (including mandatory length of
stay with surgery or emergency room coverage), limit the ability to manage care
and require contracting with all willing providers.  If enacted, certain of
these proposals could have an adverse effect on the Company.  See Item 7,
"Management's Discussion and Analysis of Financial Condition and Results of
Operations - Health Care Reform" in Part II of this Report.


Risk Management

         The HMOs maintain general liability and professional liability
(medical malpractice and managed care liability) insurance coverage in amounts
the Company believes to be adequate.  Contracting physicians are also required
to maintain professional liability coverage.  In addition to liability
coverage, the Company carries "stop-loss" insurance to reimburse its HMOs for
costs resulting from catastrophic illnesses.  This insurance generally covers
costs in excess of $500,000 up to $1 million for any enrollee in any one year
for the St. Louis, Pennsylvania and Richmond Health Plans for commercial HMO
members, costs in excess of $150,000 up to $1 million for any Medicare enrollee
in any one year and costs in excess of $50,000 up to $1 million for any
Medicaid enrollee in any year. Some coinsurance contributions by the Company
are required.  CHLIC maintains stop-loss insurance for the flexible provider
products that generally covers costs in excess of $150,000 for any enrollee in
any one year up to $1 million per enrollee per year.  No assurance can be given
as to the future availability or costs of such insurance or that risks will not
exceed the limit of the insurance coverage.


                                      7
<PAGE>   10

Employees


         At December 31, 1996, the Company employed approximately 3,200
persons.  None of the employees are covered by a collective bargaining
agreement.


Trademarks

         The Company has the right to use the name "HealthAmerica" in Illinois,
Missouri, Pennsylvania and West Virginia.  The Company has federal and/or state
registered service marks for "HealthAssurance," "GHP Access," "HealthCare USA,"
"Doc Bear," "CarePlus," "Coventry" and "Advantra."


Risk Factors

         The Company's business is subject to numerous risks and uncertainties
which may affect the Company's results of operations in the future and may
cause such future results of operations to differ materially and adversely from
projections included in or underlying any forward-looking statements made by or
on behalf of the Company.  Among the factors that may adversely affect the
Company's business are difficulties in increasing premiums to cover increasing
health care costs because of competitive pressures, regulatory restrictions and
consumer preference for lower-priced health care options.  The Company may also
experience difficulties in obtaining and maintaining favorable contracts with
health care providers and in predicting and controlling future health care
costs. Accordingly, there may be potential discrepancies between reserves for
incurred but not reported liabilities and the actual amount of such
liabilities. To the extent that the Company becomes a party to global
capitation agreements with a single provider organization, the Company becomes
exposed to credit risk with respect to such organization.

         The nature of acquisitions gives rise to the possibility of incurred
but not reported medical costs and contingent liabilities that may be
undervalued at the time of acquisition. The Company may be required to write
off the cost of certain assets if the expected results of an acquisition are
not achieved.  In selling assets, expected values may not be realized.

         The Company's recent financial losses may make it more difficult to
obtain financing on as favorable terms in the future. In addition, operating
losses at a subsidiary may require the Company to make investments in, or to
refinance Company obligations to, such subsidiary in order to maintain required
capital levels.

         The Company is also subject to risks associated with offering Medicaid
and Medicare risk products, including pricing and other regulatory
restrictions, potentially higher medical loss ratios and risks associated with
entering new markets.  As discussed in "Government Regulation", the Company's
financial results are also susceptible to future state and federal regulatory
measures, including health care reform.

         In addition, the health care industry in general is susceptible to
litigation and insurance risks, including medical malpractice liability,
disputes relating to the denial of coverage and the adequacy of "stop-loss"
reinsurance for costs resulting from catastrophic injuries or illnesses to the
Company's members.  The Company has contingent litigation risk with certain
discontinued operations.  Such litigation may result in losses to the Company.

         This Annual Report on Form 10-K and other filings and statements made
on behalf of the Company include forward-looking information which is based on
current expectations at the time the filing or statement is made and is subject
to a number of risks and uncertainties.  Forward-looking statements, which are
made in reliance on the safe harbor provided by the Private Securities
Litigation Reform Act of 1995, may be affected by a number of factors,
including the risk factors identified herein.



                                      8
<PAGE>   11




Item 2:  Description of Property

         The Company leases in aggregate approximately 350,310 square feet of
office space primarily for administrative offices in western Pennsylvania,
central Pennsylvania, St. Louis, Missouri, Jacksonville, Florida and its
corporate office in Nashville, Tennessee.  In addition, the Company has 33
medical centers, of which 28 are leased for terms of one to fifteen years and
summarized as follows:

<TABLE>
<CAPTION>
                                           Number of Leased Medical          Approximate Leased Square
         Location                                Center Sites                         Footage
---------------------------                ------------------------          -------------------------
 <S>                                                  <C>                             <C>
 Western Pennsylvania                                 11                              179,181
 Central Pennsylvania                                  8                               43,230
 St. Louis                                             9                              108,884
 Richmond                                              -                                 -
 Jacksonville                                          -                                 -
                                           ------------------------          -------------------------
 Total                                                28                              331,295
                                           ========================          =========================
</TABLE>

         The Company owns three medical centers in western Pennsylvania, two in
St. Louis and an administrative building in Richmond. Combined, these
properties have approximately 175,454 square feet.

         The medical office sites in western Pennsylvania and St. Louis,
Missouri are included in the agreements to sell certain medical offices. See
"Delivery Systems."

         In 1997, the Company plans to enter into a new lease agreement for the
administrative offices located in Harrisburg, Pennsylvania.  Renovations of
other administrative offices will be completed as necessary.



                                      9
<PAGE>   12


Item 3:  Legal Proceedings

         In the normal course of business, the Company has been named as
defendant in various other legal actions seeking payments for claims denied by
the Company, medical malpractice, and other monetary damages.  The claims are
in various stages of proceedings and some may ultimately be brought to trial.
Incidents occurring through December 31, 1996 may result in the assertion of
additional claims.  With respect to medical malpractice, the Company carries
professional malpractice and general liability insurance for each of its
operations on a claims made basis with varying deductibles for which the
Company maintains reserves.  In the opinion of management, the outcome of any
of these actions will not have a material adverse effect on the financial
position or results of operations of the Company.



Item 4:  Submission of Matters to a Vote of Security Holders

         No matters were submitted to a vote of security holders during the
fourth quarter of the fiscal year 1996.




                                      10
<PAGE>   13




                                    PART II


Item 5:  Market for the Registrant's Common Equity and Related Stockholder
         Matters


Price Range of Common Stock

         Coventry Corporation common stock is traded in the Nasdaq Stock
Market's National Market under the symbol "CVTY."   The following tables show
the quarterly range of high and low closing sales prices of the common stock on
Nasdaq during the calendar period indicated:

<TABLE>
<CAPTION>
                                              1996                                 1995
--------------------------------------------------------------------------------------------------
                                       High           Low                    High            Low
--------------------------------------------------------------------------------------------------
<S>                                  <C>            <C>                     <C>             <C>
First Quarter                        $20 7/8        $15 11/16               $30             $23 3/4
Second Quarter                       $20 15/16      $15 1/4                 $29 1/2         $13 1/2
Third Quarter                        $15 5/8        $11 15/16               $21 1/4         $14 1/4
Fourth Quarter                       $11 1/2        $9                      $22 1/8         $17 5/8
</TABLE>

<TABLE>
<CAPTION>
                                              1997
-------------------------------------------------------------
                                      High            Low
-------------------------------------------------------------
<S>                                  <C>            <C>
Through March 14, 1997               $11 3/8        $6 7/8
</TABLE>

         As of March 24, 1997, the Company had approximately 12,000
shareholders, including persons or entities holding common stock in nominee
name, and 583 shareholders of record.


Dividends

         The Company has not paid any cash dividends on its common stock and
expects for the foreseeable future to retain all of its earnings to finance the
development of its business.  The Company's ability to pay dividends is also
restricted by insurance regulations applicable to its subsidiaries and by the
terms of its credit facility.  Subject to the terms of such insurance
regulations and the Company's credit facility, any future decision as to the
payment of dividends will be at the discretion of the Company's Board of
Directors and will depend on the Company's earnings, financial position,
capital requirements and other relevant factors.  See Part II, Item 7,
"Management's Discussion and Analysis of Financial Condition and Results of
Operations - Liquidity and Capital Resources" and Note G of the Notes to
Consolidated Financial Statements.



                                      11
<PAGE>   14




Item 6:  Selected Consolidated Financial Data

(in thousands, except per share data)

Operations Statement Data (1)
<TABLE>
<CAPTION>
                                                                               Year Ended December 31,
---------------------------------------------------------------------------------------------------------------------------------
                                                             1996            1995           1994           1993            1992
---------------------------------------------------------------------------------------------------------------------------------
<S>                                                      <C>             <C>            <C>             <C>             <C>
Operating revenues                                       $1,057,129       $ 852,390     $ 776,643       $ 641,573       $ 475,454
---------------------------------------------------------------------------------------------------------------------------------
Operating earnings (loss)                                $  (91,346)      $  (1,275)    $  55,023       $  43,177       $  27,913
---------------------------------------------------------------------------------------------------------------------------------
Earnings (loss) from continuing
  operations (2)                                         $  (61,287)      $      18     $  29,288       $  22,005       $  14,171
Loss on disposal of discontinued operations                       -               -             -               -          (3,846)
Extraordinary items                                               -               -             -               -           4,005
---------------------------------------------------------------------------------------------------------------------------------
Net earnings (loss)                                      $  (61,287)      $      18     $  29,288       $  22,005       $  14,330
---------------------------------------------------------------------------------------------------------------------------------
Earnings (loss) per share (3):
        Continuing operations                            $    (1.86)      $    0.00     $    0.93       $    0.74       $    0.51
        Discontinued operations                                   -               -             -               -           (0.14)
        Extraordinary items                                       -               -             -               -            0.15
---------------------------------------------------------------------------------------------------------------------------------
        Net earnings (loss) per share                    $    (1.86)      $    0.00     $    0.93       $    0.74       $    0.52
---------------------------------------------------------------------------------------------------------------------------------

Weighted average common and common equivalent
shares outstanding (3)                                       33,011          32,164        31,425          29,585          27,547
---------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<CAPTION>
Balance Sheet Data (1)
                                                                                     December 31,
---------------------------------------------------------------------------------------------------------------------------------
                                                            1996            1995          1994           1993            1992
---------------------------------------------------------------------------------------------------------------------------------
<S>                                                       <C>             <C>           <C>             <C>             <C>
Cash and investments (4)                                  $ 173,396       $ 147,777     $ 133,975       $ 116,014       $  65,488
Total assets                                              $ 448,945       $ 385,675     $ 343,771       $ 266,971       $ 207,836
Notes payable and long-term debt (including
current maturities)                                       $  93,759       $  67,907     $  69,531       $  44,185       $  52,541
Stockholders' equity and partners' capital (5)            $ 100,427       $ 153,851     $ 134,124       $  96,906       $  69,679
</TABLE>


(1)      All periods presented have been restated for the merger with HCUSA in 
         1995, Southern Health Management Corporation ("SHMC") in 1994 and for
         discontinued operations.

(2)      Interest expense on all outstanding debt for all periods has been
         attributed to continuing operations.

(3)      Reflects the two-for-one split of the Company's common stock which
         occurred in August, 1994.

(4)      Certain reclassifications have been made to the 1994 and 1995
         financial statements to conform to the 1996 presentation.

(5)      Predecessor company of SHMC was an S Corporation.


                                      12
<PAGE>   15

Supplementary Financial Information

         The following is a summary of unaudited quarterly results of
operations (in thousands, except per share data) for the years ended December
31, 1996 and 1995.

<TABLE>
<CAPTION>
                                                                                 Quarter Ended
                                                           March 31,        June 30,       September 30,       December 31,
                                                            1996(1)         1996(2)            1996              1996(3)
                                                           --------------------------------------------------------------  
<S>                                                        <C>             <C>               <C>                <C>
Operating revenues                                         $ 236,937       $ 257,737         $  272,903         $ 289,552
Operating earnings (loss)                                  $  (2,772)      $ (14,346)        $      143         $ (74,371)
Net earnings (loss)                                        $    (968)      $  (8,528)        $      348         $ (52,139)
Net earnings (loss) per common and                         
  common equivalent share                                  $   (0.03)      $   (0.26)        $     0.01         $   (1.58)
                                                          ---------------------------------------------------------------
Weighted average common and common                            
  equivalent shares outstanding                               32,854          33,041             33,021            33,024
                                                          ---------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>
                                                                                 Quarter Ended
                                                           March 31,      June 30,         September 30,       December 31,
                                                             1995          1995(4)            1995(5)            1995(6)
                                                           --------------------------------------------------------------
<S>                                                        <C>            <C>                 <C>               <C>
Operating revenues                                         $ 209,652      $ 208,868           $ 211,137         $ 222,733
Operating earnings (loss)                                  $  16,253      $   4,764           $   1,118         $ (23,410)
Net earnings (loss)                                        $   9,870      $   2,177           $   1,494         $ (13,523)
Net earnings (loss) per common and                         
  common equivalent share                                  $    0.30      $    0.07           $    0.05         $   (0.42)   
                                                           --------------------------------------------------------------
Weighted average common and common                            
  equivalent shares outstanding                               32,402         32,157              31,952            32,416
                                                           --------------------------------------------------------------
</TABLE>

(1) The first quarter operating results were affected by termination and 
    related costs to streamline the Company's administrative process and
    reduce staffing in health centers, primarily in the Pennsylvania and St.
    Louis plans for total adjustments of $5.2 million.

(2) The second quarter operating results were affected by the establishment of 
    reserves relating to multi-year contracts with certain employer groups,
    primarily in the St. Louis market.  The Company expects to utilize these
    reserves over the remaining lives of the contracts and then either
    discontinue the contracts or significantly change the terms and conditions
    of the contracts with these parties.  The establishment of these reserves
    resulted in total adjustments of $8.2 million.

(3) The fourth quarter operating results were affected by the increase of 
    reserves related to accounts receivable ($3.6 million), long-term
    contracts ($1.6 million), medical claims ($25.6 million), termination costs
    ($2.1 million), other reserves ($6.0 million), write-offs of goodwill ($21.0
    million) and certain capitalized expenses ($6.7 million).

(4) The second quarter operating results of 1995 were affected by merger costs 
    for the purchase of HCUSA, severance and related costs associated with
    staff restructuring in Pittsburgh and St. Louis, additions to accruals for
    professional liability litigation and the settlement of certain Office of
    Personnel Management negotiations for total adjustments of approximately
    $7.0 million.

(5) The third quarter operating results of 1995 were affected by an increase in
    medical claims liabilities for the western Pennsylvania market and
    start up expenses associated with Medicaid and Medicare product development
    and geographic expansion initiatives for total adjustments of approximately
    $6.5 million.

(6) The fourth quarter operating results of 1995 were affected by the 
    elimination of several of its new market development areas, personnel
    reductions in its operations and increases in legal, medical and
    contingency reserves for total adjustments of $21.8 million.


                                      13
<PAGE>   16





Item 7:  Management's Discussion and Analysis of Financial Condition and
         Results of Operations

    Coventry Corporation, headquartered in Nashville, Tennessee, is a managed
health care company that provides comprehensive health benefits and services to
a broad cross section of employer and government-funded groups in Pennsylvania,
Ohio, West Virginia, Missouri, Illinois, Virginia and Florida.

    Management's Discussion and Analysis of Financial Condition and Results of
Operations contains forward-looking information which is based upon current
expectations and involves a number of risks and uncertainties.  The forward-
looking statements, which are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995, may be affected by a
number of factors, including the risk factors set forth in the Company's Annual
Report on Form 10-K, and consequently, actual operations and results may differ
materially from those expressed in these forward-looking statements.  Among the
factors that may materially affect the Company's business are potential
increases in medical costs, difficulties in increasing premiums due to
competitive pressures, imposition of regulatory restrictions, difficulties in
obtaining or maintaining favorable contracts with healthcare providers,
financing costs and contingencies and litigation risk.

    During the three year period ended December 31, 1996, the Company
experienced substantial growth in operating revenues due primarily to
membership growth.  The Company achieved this membership growth through
marketing efforts, acquisitions, geographic expansion and increased product
offerings, including the introduction of Medicare and Medicaid risk products in
1995.

    The acquisition of HealthCare USA in 1995 allowed the Company to enter the
Medicaid product market.  Through HealthCare USA, the Company obtained a
presence in the Florida Medicaid market and entered the St. Louis and central
Missouri Medicaid markets during 1995, and continued to grow enrollment
throughout 1996.  At December 31, 1996, approximately 120,000 Coventry members
were enrolled in a Medicaid risk product.

    The Company began marketing its Medicare risk product in the St. Louis, 
Missouri market in late 1995, and began marketing that product in the western
and central Pennsylvania markets in 1996.  At December 31, 1996, the Company
had approximately 27,000 Medicare members, including both risk and cost based
members.

    The Company's managed care premium revenues during the three year period
ended December 31, 1996 were comprised primarily of commercial premiums from
its HMO products and flexible provider products, including PPO and POS products
for which the Company assumes full underwriting risk.  Fully insured PPO/POS
premiums are typically lower than HMO premiums due to the medical underwriting
and the deductibles and copayments required from the PPO/POS members.
Additional revenue is earned for other medical services provided on a
fee-for-service basis in Company-operated medical offices.

    Premium rates for commercial HMO products are reviewed by various state 
agencies based on rate filings.  While the Company has not had such filings
modified, no assurance can be given that approvals for rate submissions will
continue. Premium rates for the Medicaid and Medicare risk products are
established by governmental regulatory agencies and may be reduced by
regulatory action. No assurance can be given that premium rates will not
decrease in the future.

    The Company's management services revenues result from operations in which
the Company's health plans provide administrative and other services to
self-insured employers. The Company receives an administrative fee for these
services, but does not assume underwriting risk.  A portion of these revenues,
however, are dependent upon the Company meeting specific performance criteria.


                                      14
<PAGE>   17




    The Company's operating expenses are primarily medical costs including
medical claims under contracted relationships with a wide variety of providers,
capitation payments and expenses relating to the operation of the Company's
health centers.  Medical claims expense also includes an estimate of claims
incurred but not reported ("IBNR"). The Company believes that the estimates for
IBNR liabilities relating to its businesses are adequate in order to satisfy
its ultimate claims liability with respect thereto.  The estimated IBNR is
based on historical data, current enrollment, health service utilization
statistics and other related information, determined on an actuarial basis.
Changes in assumptions for medical costs caused by changes in actual experience
could cause these estimates to change in the near term.  The Company
periodically monitors and reviews IBNR, and as settlements are made or accruals
adjusted, differences are reflected in current operations.

    Effective January 1, 1996, the Company adopted Statement of Financial
Accounting Standards Number 121 ("SFAS 121"), "Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed of" and Statement of
Financial Accounting Standards Number 123 ("SFAS 123"), "Accounting for
Stock-Based Compensation." The adoption of provisions of SFAS 121 and SFAS 123
had no material effect on the financial position or results of operations of
the Company.

    The following discussion should be read in conjunction with the
accompanying consolidated financial statements and notes.


Results of Operations

    The following table (in thousands, except percentages and membership data)
is provided to facilitate a more meaningful discussion regarding the results of
the Company's operations for the three years ended December 31, 1996.

<TABLE>
<CAPTION>
                                                1996                                  1995                            1994
                                     -------------------------------      --------------------------------     -------------------
                                                 Percent                             Percent                              Percent 
                                                   of       Percent                    of         Percent                   of 
                                                Operating   Increase                Operating     Increase               Operating
                                       Amount    Revenues  (Decrease)      Amount   Revenues     (Decrease)      Amount   Revenues  
----------------------------------------------------------------------------------------------------------------------------------
<S>                                  <C>         <C>         <C>          <C>       <C>           <C>           <C>        <C>
Operating revenues:
    Managed care premiums            $1,035,778  98.00 %      22.7%       $844,032   99.0 %        9.6 %        $769,935   99.1 %
    Management services                  21,351   2.00 %     155.5%          8,358    1.0 %       24.6 %           6,708    0.9 %
----------------------------------------------------------------------------------------------------------------------------------
      Total operating revenues        1,057,129 100.00 %      24.0%        852,390  100.0 %        9.8 %         776,643  100.0 %
----------------------------------------------------------------------------------------------------------------------------------
Operating expenses:
    Health benefits (1)                 930,739  88.00 %      30.5%        713,226   83.6 %       16.1 %         614,144   79.1 %
    Selling, general and administrative 165,081  15.60 %      33.6%        123,523   14.5 %       30.5 %          94,684   12.2 %
    Depreciation and amortization        42,862   4.10 %     192.3%         14,666    1.7 %       55.4 %           9,437    1.2 %
    Other charges                         9,793   0.90 %        --                                
    Merger costs                                                             2,250    0.3 %      (32.9)%           3,355    0.4 %
----------------------------------------------------------------------------------------------------------------------------------
Operating earnings (loss)               (91,346) (8.60)%        NM          (1,275)  (0.1)%     (102.3)%          55,023    7.1 %
Other income, net                        13,379   1.20 %      73.6%          7,705    0.9 %       54.0 %           5,003    0.6 %
Interest expense                         (6,257) (0.60)%      28.2%         (4,881)  (0.6)%       78.7 %          (2,731)  (0.4)%
----------------------------------------------------------------------------------------------------------------------------------
Earnings (loss) before
    income taxes and
    minority interest                   (84,224) (8.00)%        NM           1,549    0.2 %      (97.3)%          57,295    7.4 %
----------------------------------------------------------------------------------------------------------------------------------
Net earnings (loss)                  $  (61,287)                         $      18                             $  29,288
==================================================================================================================================

Membership at December 31:
    Commercial                          592,001                            510,815                               468,743
    Medicare (2)                         27,507                             18,890                                19,068
    Medicaid                            121,599                             73,550                                26,143
    Management services                 152,969                             92,232                                67,003
----------------------------------------------------------------------------------------------------------------------------------
                                        894,076                            695,487                               580,957
==================================================================================================================================
</TABLE>

(1) The medical loss ratio (health benefits as a percentage of managed care
premiums) was 89.9%, 84.5% and 79.8% in 1996, 1995 and 1994, respectively.

(2) Includes both full risk and cost-based members.


                                      15
<PAGE>   18

Comparison of 1996 to 1995

    Managed care premiums increased $191.7 million, or 22.7%, to $1,036 million
for the year ended 1996 compared to 1995.  The increase was primarily
attributable to the 137,852 member, or 22.9%, increase in risk membership from
the prior year.  Of this enrollment growth, 48,049 members, or 35%, were
related to the Medicaid product and 81,186 members or 59%, were commercial
members. The effect on revenues of the increased membership was partially
offset by changes in commercial membership mix, with an increased percentage of
that membership composed of the lower premium PPO and POS products compared to
the HMO products, and a 4.3% decline in average HMO premium yield.  Membership
as of December 31, 1996 and 1995 was as follows:

<TABLE>
<CAPTION>
                                         Commercial              Medicare
                                      HMO        PPO/POS      Cost       Risk        Medicaid        Non-Risk     Total
                1996                -------------------------------------------------------------------------------------
         <S>                        <C>          <C>         <C>         <C>          <C>            <C>          <C>
         Western PA                 149,530       92,052      1,957       4,994         2,298         45,565      296,396
         Central PA                 115,780       44,704        466         365        11,836         71,900      245,051
         St. Louis                   92,895       39,579      4,794      14,931        76,829         24,574      253,602
         Richmond                    57,047          104                                2,904         10,930       70,985
         Jacksonville                   310                                            27,732                      28,042
                                    -------------------------------------------------------------------------------------
           Total                    415,562      176,439      7,217      20,290       121,599        152,969      894,076
                                    =====================================================================================

                1995

         Western PA                 144,498       71,896      4,782                                   30,977      252,153
         Central PA                 102,772       17,154        443                                   38,391      158,760
         St. Louis                   87,973       28,726     13,234         431        47,388         11,895      189,647
         Richmond                    55,267        2,529                                              10,969       68,765
         Jacksonville                                                                  26,162                      26,162
                                    -------------------------------------------------------------------------------------
           Total                    390,510      120,305     18,459         431        73,550         92,232      695,487
                                    =====================================================================================
</TABLE>


    The Company experienced competitive pressures in its commercial products,
which negatively affected the average premium the Company received and the mix
of commercial products sold during 1996.  The Company anticipates continued
enrollment gains in 1997, although at a slower rate than seen in 1996.
Enrollment gains are expected to be lower than gains realized in prior years as
the Company focuses on profitability of current products and lines of business,
including efforts to increase the average premium yield.  No assurances can be
given that increased yields are attainable. The Company anticipates losing
certain customers due to more stringent underwriting practices.

    Gains in Medicaid and Medicare enrollments increased the Company's exposure
to government regulation of premium levels and other requirements.  The impact
of legislative or regulatory changes in the Medicaid and Medicare programs
could adversely affect enrollment, premiums and profitability of these
products. 

    Management services revenues increased approximately $13.0 million, or 
155.5% from the prior year.  The increase is attributable to the approximately
60,737 member increase in this product.

    Health benefits expense increased $217.5 million, or 30.5%, in 1996
compared to 1995 as a result of the increase in full-risk enrollment and
increases in medical costs.  As a result of the declining premium yields
discussed above and increases in medical costs, including the effects of a
decline in the proportion of risk membership utilizing staff medical facilities
in Pittsburgh, Pennsylvania and St. Louis, Missouri, the medical loss ratios
increased in all of the Company's markets as follows:

<TABLE>
<CAPTION>
                                                 1996                               1995
                                                 -----                              ----- 
 <S>                                             <C>                                <C>
 Western Pennsylvania                            88.9%                              87.3%
 Central Pennsylvania                            89.2%                              80.0%
 St. Louis                                       89.7%                              86.2%
 Richmond                                        87.6%                              82.5%
 Jacksonville                                    86.7%                              80.0%

   Total                                         89.9%                              84.5%
</TABLE>


                                      16
<PAGE>   19






    Health benefits expense increased on a per member per month basis from 1995
in all markets.  The increases in medical costs are attributable to increases
in the costs of inpatient services related to its Medicaid operations, 
inpatient alternatives (such as outpatient surgery) and pharmacy. 
Additionally, membership in the Company's western Pennsylvania medical office
operations, which declined during 1995 primarily as a result of the loss of two
significant accounts did not recover in 1996, continuing the excess capacity
problem for the medical office operations.

    In March 1997, the Company entered into agreements to sell the Company's
medical offices in western Pennsylvania and St. Louis, Missouri to major
provider organizations in these markets.  The agreements are subject to the
satisfaction of various conditions, including regulatory approval.  Coincident
with the sale of the medical offices, the Company will enter into long-term
global capitation arrangements with the purchasers of the medical offices,
pursuant to which the provider organizations will receive a fixed percentage of
premium to cover all of the costs of medical treatment the Company's globally
capitated  members receive from the health care systems.  The Company
anticipates these arrangements will reduce its medical costs as a percentage of
premiums in western Pennsylvania and St. Louis, Missouri.  

    The Company has determined that its Florida Medicaid operations are 
unlikely to be sufficiently profitable on a long-term basis to justify a
continued presence in the Florida market and, as a result, the Company is
considering exiting the Florida Medicaid market.  Accordingly, the Company has
established a reserve of $1.2 million at December 31, 1996 to reflect the
anticipated costs of exiting this market.   

    In the fourth quarter of 1996, the Company increased medical reserves by 
$25.6 million, attributable to the Company's quarterly process for adjusting
for settlements of prior quarters.  Medical claim liability accruals are
periodically monitored and reviewed with differences reflected in current
operations. Medical costs are affected by a variety of factors, including the
severity and frequency of claims, that are difficult to predict and may not be
entirely within the Company's control.

    Selling, general, and administrative expense ("SGA") increased $41.6
million, or 33.6%, from 1995.  As a percentage of total operating revenues, SGA
increased from 14.5% in 1995 to 15.6% in 1996 due to increases in costs,
declines in commercial premiums and the items discussed below.  The Company 
decided to cease start-up development activities in certain markets in 1996. 
As a result of narrowing the focus of new market development, certain
capitalized costs totaling $4.3 million were charged to SGA in 1996.  During
1996, the Company also recorded approximately $8.1 million of charges related
to personnel terminations and related severance. These charges resulted from
administrative and medical office staff reductions due to excess capacity and
the outsourcing of certain ancillary services capabilities.  Additionally,
provisions for uncollectible accounts and other charges related to SGA of
approximately $9.0 million were recorded in 1996.

    Depreciation and amortization increased $28.2 million, or 192.3%, from
1995.  This increase was due primarily to the write-off of goodwill related to
the recently acquired PARTNERS Health Plan of Pennsylvania, Inc. of $20.1
million, write-downs of fixed assets of approximately $4.3 million and
incremental depreciation expense recognized on additions to property and
equipment.

    Other charges consisting of provisions for multi-year contracts of $9.8 
million were recorded in 1996 to recognize anticipated losses on certain
multi-employer group contracts, primarily in the St. Louis market.  The Company
expects to utilize these reserves over the remaining lives of the contracts and
then either discontinue these contracts or significantly change the terms and
conditions of the contracts with these parties.  The contracts expire at
varying dates through 1999 and cover approximately 30,000 members.

    Operating earnings for the year 1996 decreased $90.1 million from 1995
operating earnings.  The decrease is primarily attributable to the decline in
commercial yield, the increases in medical claims expense, the increase in
IBNR reserves, the asset write-downs and other charges noted above.

    Other income, net increased $5.7 million, or 73.6%, from 1995.  This
increase was primarily due to a $4.9 million gain on the sale of Champion
Dental Services, Inc. recorded in the fourth quarter of 1996.


                                      17
<PAGE>   20


    Interest expense increased $1.4 million in 1996 over the prior year
primarily due to a higher average outstanding debt balance for the year and an
increased interest rate on long-term debt.  The majority of the approximately
$35 million purchase price of PARTNERS Health Plan of Pennsylvania, Inc. was
funded through borrowings on the Company's long-term credit agreement.

    Provision for income taxes reflects a consolidated effective income tax
benefit rate of 27.1% for 1996 compared to a provision of 98.7% for 1995.  The 
increase in nondeductible goodwill amortization is the primary cause of the low
effective income tax benefit rate in 1996.

    Loss for the year 1996 was $61.3 million.  Loss per common and common
equivalent share was $1.86 in 1996 compared to $0.00 in the prior year.  The
weighted average common and common equivalent shares outstanding increased to
33.0 million in 1996 compared to 32.2 million in 1995.


Comparison of 1995 to 1994

    Managed care premiums increased $74.1 million, or 9.6%, to $844.0 million
for the year ended 1995 compared to 1994.  The increase was primarily
attributable to the 89,301 members, or 17.4%, increase in risk membership from
the prior year.  Of this enrollment growth, 47,047 members, or 53%, related to
the Medicaid product. The effect of the increased membership on revenues was
partially offset by changes in membership mix, with membership shifting from
HMO products to the PPO and POS products which have lower per member premiums.

    During 1995, the Company introduced its Medicare risk product and expanded
the Medicaid product. The Company had limited experience with the Medicaid and
Medicare products, and as a result, with their underwriting, pricing, and
utilization patterns.  Gains in Medicaid and Medicare enrollments increased the
Company's exposure to government regulation of premium levels and other
requirements.  Premium rates paid to the Company's Medicaid operations in
Florida declined in the third quarter of 1995.

    Furthermore, in 1995 the Company experienced competitive pressures in its
commercial products, which negatively affected the average premium that the
Company has historically received from new and existing members, the membership
growth opportunities and the mix of products sold.  The average commercial
premium received by the Company declined in 1995 by 1.6%.

    Management services revenues increased $1.7 million, or 24.6% from the
prior year.  The increase is attributable to the approximately 25,200 members,
or 37.7%, increase in this product line.  Approximately 10,600 of these new
non-risk members resulted from the acquisition of a Virginia third party
administrator in May 1995.

    Health benefits expense increased $99.1 million, or 16.1%, in 1995 compared
to 1994 as a result of the increase in full-risk enrollment and increases in
medical costs.  The medical loss ratios increased in all of the Company's
markets as follows:

<TABLE>
<CAPTION>
                                                  1995                              1994
                                                 -----                              -----
 <S>                                             <C>                                <C>
 Western Pennsylvania                            87.3%                              77.7%
 Central Pennsylvania                            80.0%                              78.4%
 St. Louis                                       86.2%                              85.3%
 Richmond                                        82.5%                              80.6%
 Jacksonville                                    80.0%                              70.1%

   Total                                         84.5%                              79.8%
</TABLE>


                                      18
<PAGE>   21
    In the western Pennsylvania market, health benefits expense increased 15.5%
on a per member per month basis from 1994.  The increase in medical costs in
the western Pennsylvania market was attributable to higher utilization of
inpatient alternatives and consultant services, and in general, each of the
markets experienced increases in the costs of inpatient services, inpatient
alternatives and consultant services relative to premium increases.
Additionally, membership in the western Pennsylvania's medical office
operations declined during 1995 primarily as a result of the loss of two
significant accounts.  Because the operating costs of the medical offices were
not reduced, the loss of membership created excess capacity.  The premium rate
reduction in the third quarter of 1995 in HealthCare USA's Jacksonville
Medicaid operations also contributed to the increase in the medical loss ratio.

    In the fourth quarter, the Company increased medical reserves,
primarily for the western Pennsylvania market, in the course of the Company's
quarterly process for adjusting for settlements of prior quarters.  The total
increase to medical reserves was approximately $13 million.

    Selling, general, and administrative expense increased $28.8 million, or
30.5%, from 1994.  As a percentage of total operating revenues, SGA increased
from 12.2% in 1994 to 14.5% in 1995.  During 1995, the Company recorded
approximately $3.0 million of charges related to personnel terminations and
related severance.  In the fourth quarter of 1995, the Company decided to
narrow the focus of start-up development activities in 1996, while
concentrating development and growth efforts in existing and contiguous markets
and, as a result, certain capitalized costs were written off at year-end. 
Additionally, reserves for litigation and other contingencies were established.
These year-end charges, totaling $7.3 million, were charged to SGA in 1995.

    The increase in SGA represents primarily product introduction costs,
including additional personnel and systems support for government products
introduced in 1995.  These costs also include other selling, general and
administrative costs associated with the geographic expansion of the western
Pennsylvania market to West Virginia and eastern Ohio and additional
administrative services capabilities.

    Depreciation and amortization increased $5.2 million, or 55.4%, from 1994.
This increase was due primarily to the amortization of the goodwill resulting
from the purchase of the remaining 20% Penn Group Corporation minority interest
and increased depreciation expense corresponding to additions in net property
and equipment from 1994.

    Merger costs of $2.3 million include all costs associated with the
HealthCare USA merger which was accounted for as a pooling of interests.  The
1994 costs were associated with the acquisition of Southern Health Management
Corporation in Richmond, Virginia.

    Operating earnings for the year 1995 decreased $56.3 million from 1994
operating earnings.  The decrease is primarily attributable to the increase in
medical claims expense, SGA, and depreciation and amortization described above.

    Other income, net, consists primarily of investment income and increased
$2.7 million, or 54%, from 1994.  This increase was primarily due to the
increase in cash and investments during the year.

    Interest expense increased $2.2 million in 1995 over the prior year due to
a higher average outstanding debt balance for the year.  Effective October 31,
1994, the Company purchased the remaining 20% minority interest in Penn Group
Corporation for $50 million.  The majority of the purchase price was funded
through borrowings on the credit facility.


                                      19
<PAGE>   22




    Provision for income taxes reflects a consolidated effective income tax
rate of 98.7% for 1995 compared to 42.6% for 1994.  The increase was primarily
due to merger costs of $2.3 million, which are not deductible for tax purposes.
The ratio of these costs to pretax earnings was significantly higher in 1995
than in 1994.

    Minority interest in earnings of consolidated subsidiary, net of income
taxes decreased $3.6 million in 1995 compared to 1994.  The 1994 income
reflects ten months of the 20% minority interest in the Company's Pennsylvania
HMO which was held by a third party until its purchase in the fourth quarter of
1994.  The 1995 minority interest amount reflects a minority shareholder's 30%
interest in Healthcare USA, LLC, the St. Louis-based Medicaid HMO.

    Net earnings decreased $29.3 million, or 99.9%, for the year 1995 compared
to 1994.  Earnings per common and common equivalent share was $0.00 compared to
$0.93 in the prior year.  The weighted average common and common equivalent
shares outstanding increased to 32.2 million in 1995 compared to 31.4 million
in 1994.


Discontinued Operations

    Effective January 1, 1995, the Company entered into an agreement with
United Insurance Companies, Inc. ("United"), whereby United assumption
reinsured a closed book of business comprised of traditional indemnity
insurance policies that were offered by the Company's insurance subsidiary
prior to 1993.  United has managed these discontinued operations since December
1992. Under the terms of the agreement, United assumed substantially all of the
closed book of business claims, unearned premium reserves, and all other
statutory liabilities, except for certain litigation reserves that are retained
by the Company.


Litigation and Insurance

    The Company may be subject to certain types of litigation, including
medical malpractice claims; claim disputes pertaining to contracts and other
arrangements with providers, employer groups and their employees and individual
members; and disputes relating to HMO denials of coverage for certain types of
medical procedures or treatments.  In addition, the Company has contingent
litigation risk in connection with certain discontinued operations.  Such
litigation may result in losses to the Company.  The Company maintains
insurance coverage in amounts the Company believes to be adequate including
professional liability (medical malpractice) and general liability insurance.
Contracting physicians are required to maintain professional liability
insurance.  In addition, the Company carries "stop-loss" reinsurance to
reimburse it for costs resulting from catastrophic injuries or illnesses to its
members.  Nonetheless, no assurance can be given as to the future availability
or cost of such insurance and reinsurance or that litigation losses will not
exceed the limits of the insurance coverage and reserve.  In the opinion of
management and based on the facts currently known, the outcome of these actions
will not have a material adverse effect on the financial position or results of
the operations of the Company.


New Accounting Standards

    The Financial Accounting Standards Board has approved statements of
financial accounting standards effective for fiscal period ending after December
15, 1997, which establishes standards for computing and presenting earnings per
share and also establishes standards with respect to disclosure of information
about an entity's capital structure.  The Company is required to adopt the
provisions in the fourth quarter of 1997 and does not expect the adoption
thereof to have a material effect on the Company's financial position or
results of operations.

                                      20
<PAGE>   23

Inflation

    Health care cost inflation has exceeded the general inflation rate and the
Company has implemented cost control measures and risk sharing arrangements
which seek to reduce the effect of health care cost inflation.  During 1995 and
1996, the Company experienced downward pressure in premium rates, and as a
result has implemented further cost control measures to reduce both medical and
administrative expenses.  An inability to successfully reduce expenses as a
percentage of premium adversely impacted the Company's results of operations in
1996.


Income Taxes

    In its income tax returns, the Company is amortizing approximately $21
million of its intangible assets over periods ranging from three to eight
years.  In the consolidated financial statements in the caption "Goodwill and
Intangible Assets" is an aggregate of $116.4 million of goodwill at December
31, 1996 which, for financial reporting purposes, is being amortized over
periods not exceeding 40 years.  The different book and tax treatment arises
because the Company believes the methodologies and assumptions utilized in the
tax basis appraisal of these amounts are not appropriate for financial
reporting purposes.  The Omnibus Reconciliation Act of 1993 ("OBRA") enacted
legislation, effective January 1, 1993, whereby all intangibles, including
goodwill, acquired in certain transactions can be amortized for income tax
purposes over 15 years.  Although the provisions of the OBRA cannot be applied
to the $21 million of tax intangibles, the Company believes that the
legislation is indicative of the government's desire to minimize the costs of
intangibles controversies.  The Company believes it will eventually sustain a
tax deduction for a substantial portion of the $21 million, but such a
deduction is likely to be determined on the basis of a compromise with the
government.

    Pending a final determination of its tax position, the Company's income tax
provision has been adjusted to reflect no tax benefit in its financial
statements for the deduction of these amounts.


Quarterly Results of Operations

    The quarterly consolidated results of operations of the Company are
summarized in Note T to Consolidated Financial Statements.


Liquidity and Capital Resources

    The Company's total cash and investments, excluding restricted investments,
increased $25.6 million to $173.4 million as of December 31, 1996 compared to
$147.8 million at December 31, 1995.  This increase is primarily attributable
to $37.3 million of cash provided by operating activities and $42.7 million of
cash from other activities including bank borrowings and net proceeds from the
issuance of common stock. The cash provided was offset by $54.4 million used
for capital expenditures, debt repayment and acquisitions. The Company invests
cash not needed to fund current liabilities primarily in liquid portfolios of
fixed income securities issued by the federal government and various states and
municipalities.  Current assets plus these investments exceeded current
liabilities in 1996 by $19.7 million, compared to $49.1 million in 1995.

    The Company's HMOs and insurance subsidiaries are required by state
regulatory agencies to maintain minimum surplus balances, thereby limiting the
dividends the Company may receive from its HMOs and insurance subsidiaries.
After giving effect to these statutory reserve requirements, the Company's
regulated subsidiaries had funds in excess of statutory requirements of
approximately $41.6 million and $43.0 million at December 31, 1996 and 1995,
respectively.  Excluding funds subject to regulation, the Company had cash and
investments of approximately $16.5 million and $40.0 million in 1996 and 1995,
respectively, which are available to pay intercompany balances to regulated
companies and for general corporate purposes.


                                      21

<PAGE>   24


    In March 1997, the Company entered into a letter of intent to sell $40
million of Convertible Exchangeable Subordinated Notes (the "Convertible
Notes"), together with warrants to purchase 2.35 million shares of its common
stock to Warburg, Pincus Ventures, L.P. ("Warburg") for $42.35 million subject 
to the negotiation of definitive documentation, the approval of state insurance
regulators in certain states and the approval of the lending banks under the
Company's credit  facility.  Proceeds from the sale are expected to be used to
repay outstanding indebtedness and provide working capital.  The Convertible
Notes are expected to be convertible into 4 million shares of the Company's
common stock and will be exchangeable at the Company's option for shares of
convertible preferred stock, the authorization of which will require the
approval of the Company's shareholders at the 1997 shareholders' meeting. 

    Prior to June 30, 1996, the Company's long-term credit agreement (the
"Credit Facility") with a group of banks provided for borrowings up to $125
million. The Credit Facility called for scheduled semi-annual commitment
reductions of $20.83 million beginning February 18, 1997 with final reduction
of $20.85 million on August 18, 1999.  As a result of losses in the second
quarter of 1996, the Company was not in compliance with certain financial
covenants in the Credit Facility as of June 30, 1996. Effective September 30,
1996 the Company reached an agreement ("Amended Credit Facility") with the bank
group amending the Credit Facility.  Prior to the amendment, the Company
voluntarily reduced the availability under the Credit Facility to $100 million,
of which $90 million was outstanding at December 31, 1996.  The Amended Credit
Facility, which revised certain financial ratios the Company was required to
maintain, increased the interest rate on the indebtedness by 0.8% and revised
the required reductions in availability.  At December 31, 1996, the effective
interest rate on the indebtedness under the Amended Credit Facility was 7.56%.

    As a result of continuing losses in the fourth quarter of 1996, the 
Company was not in compliance with certain revised financial covenants in the
Amended Credit Facility and therefore was in default under the terms of the
Amended Credit Facility as of December 31, 1996.  As a result, no further
borrowings under the Amended Credit Facility were available.  Subsequent to
December 31, 1996, the Company entered into an amended and restated agreement
("Restated Credit Facility") with the bank group effective March 28, 1997 that,
along with other changes, converts the amount outstanding under the Restated
Credit Facility to a term loan, revises certain financial ratios the Company is
required to maintain, effectively increases the interest rate of the
indebtedness by 2.7% (to the greater of prime plus 2% or the federal funds rate
plus 2.5%) and revises the amortization period of the loan. The Restated Credit
Facility requires payments of $10 million on June 30, 1997, $7 million on
September 30, 1997, $18 million on December 31, 1997 and $55 million on April
1, 1998. The Restated Credit Facility eliminated the defaults that existed
under the Amended Credit Facility at December 31, 1996.

    The amendment also requires the Company to apply 50% of the net cash 
proceeds from the proposed Warburg, Pincus Ventures, L.P. transaction to the
loan balance, with the payment being applied to reduce 1997 and 1998
amortization payments.  The Restated Credit Facility also requires the Company 
to prepay loans upon receipt of an anticipated $9.5 million tax refund
resulting from the carryback of operating losses to prior years, with the
prepayment being applied to reduce the December 1997 amortization payment.

    The Restated Credit Facility requires the Company to apply 50% of the net 
cash proceeds of sales of the Company's capital stock to reduce the
scheduled amortization in the inverse order of maturity, prohibits the sale of
any substantial subsidiary and restricts the Company's ability to declare and
pay cash dividends on its common stock.  Prior to the closing of the proposed
Warburg transaction, a material adverse change in the Company's financial
condition or results of operations will constitute an event of default under
the Restated Credit Facility.

    The Restated Credit Facility contains covenants relating to investments in
non-admitted assets, operating margin, net worth levels and the creation or 
assumption of debt or liens on the assets of the Company.  The Restated Credit
Facility is collateralized by substantially all of the assets of the Company.

    On March 31, 1997, the effective interest rate on the indebtedness under
the Restated Credit Facility was 10.5%.


                                      22

<PAGE>   25

    As of December 31, 1996, approximately 96% of the Company's long-term debt
was subject to fluctuations in interest rates. 

    During 1996, the Company's capital expenditures were $12.7 million and
included the costs of constructing a new health center in St. Louis, Missouri
and expanding and renovating other medical centers and administrative offices.
Other capital expenditures included the cost of acquiring and implementing new
operational software systems designed to enhance the Company's medical
management and information reporting capabilities.

    Projected capital investments in 1997 of approximately $13 million consist
primarily of computer hardware, software and related equipment costs associated
with the development and implementation of improved operational and
communications systems and office equipment.

    The Company believes that cash flows generated from operations, cash on
hand and investments, excess funds in certain of its regulated subsidiaries,
cash flows from the sale of certain medical offices and financing alternatives
will be sufficient to fund continuing operations and debt service obligations. 
If the proposed Convertible Notes transaction is not consummated, the Company
will likely seek alternate financing in order to meet scheduled debt service
obligations. The Company's investment guidelines emphasize investment grade
fixed income instruments in order to provide short-term liquidity and minimize
the risk to principal.


Health Care Reform

    Numerous proposals have been introduced in the United States Congress and
various state legislatures relating to health care reform.  Some proposals, if
enacted, could among other things, restrict the Company's ability to raise
prices and to contract independently with employers and providers.  Certain
reform proposals favor the growth of managed health care, while others would
adversely affect managed care.  Although the provisions of any legislation
adopted at the state or federal level cannot be accurately predicted at this
time, management of the Company believes that the ultimate outcome of currently
proposed legislation would not have a material adverse effect on the Company
and its results of operations in the short run.

    As a result of the introduction of Medicare and Medicaid risk products in
1995, the Company is subject to regulatory and legislative changes in those two
government programs.


1997 Outlook

    The Company's enrollment in January 1997 increased to approximately 902,000
members, an increase of 15.5% over January 1996.  Of the January 1997
enrollment, approximately 763,000 are members under the full-risk products and
approximately 139,000 members represent lives under management services plans.

    The Company operates in highly competitive markets, but believes that the
pricing environment is improving in its existing markets, thus creating the
opportunity for reasonable price increases in the Company's market areas.
However, there is no assurance that the Company will be able to increase
premiums at rates equal to or in excess of increases in its health care costs.

    For 1997, the Company has strengthened its underwriting processes and
oversight in both risk and non-risk products with the objective of increasing
premium yields and profitable growth.  The Company will continue to pursue
global capitation arrangements as part of its delivery system with the
objectives of involving providers in medical cost management and stabilizing
operating margins.  The completion of the medical office sales in St. Louis,
Missouri and Pittsburgh, Pennsylvania will improve liquidity and eliminate the
financial losses associated with excess capacity in the Company's delivery
system.  Administrative processes in claims, information systems and customer
services are being re-engineered with emphasis on low costs and high quality.
The Company will focus on its existing markets for growth in commercial,
Medicare risk and Medicaid membership by leveraging the value of its franchises
and the volume of its membership base. The Company believes that these
objectives should result in progressive improvements in operations during 1997,
although realization of the benefit of these strategies is dependent upon a
variety of factors, some of which may be outside the control of the Company.



                                      23
<PAGE>   26




Item 8:       Financial Statements and Supplementary Data

Report of Independent Public Accountants

To the Board of Directors and Stockholders of Coventry Corporation:

         We have audited the accompanying consolidated balance sheets of
Coventry Corporation and subsidiaries as of December 31, 1996 and 1995, and the
related consolidated statements of operations, stockholders' equity and cash
flows for each of the three years in the period ended December 31, 1996.  These
consolidated financial statements are the responsibility of the Company's
management.  Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.

         We conducted our audits in accordance with generally accepted auditing
standards.  Those standards require that we plan and perform the audits to
obtain reasonable assurance about whether the consolidated financial statements
are free of material misstatement.  An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the consolidated
financial statements.  An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall consolidated financial statement presentation.  We
believe that our audits provide a reasonable basis for our opinion.

         In our opinion, the consolidated financial statements referred to
above present fairly, in all material respects, the financial position of
Coventry Corporation and subsidiaries as of December 31, 1996 and 1995, and the
results of their operations and their cash flows for each of the three years in
the period ended December 31, 1996 in conformity with generally accepted
accounting principles.


                                              ARTHUR ANDERSEN LLP


Nashville, Tennessee
February 21, 1997 (except for
Notes G and S, as to which
the date is March 31, 1997)



                                      24
<PAGE>   27




Consolidated Balance Sheets
(in thousands, except share data)

<TABLE>
<CAPTION>                                                                      
                                                                                       December 31,
------------------------------------------------------------------------------------------------------------
                                                                                  1996             1995
------------------------------------------------------------------------------------------------------------
<S>                                                                          <C>               <C>
Assets

Cash and cash equivalents                                                    $      90,619     $     67,435
Short-term investments                                                               7,388           18,408
Accounts receivable, net of allowance for doubtful                                  37,921           32,118
  accounts of $8,000 and $2,700, respectively
Other receivables                                                                   22,661           10,909
Assets held for sale                                                                23,856                -
Deferred income taxes                                                               20,449            8,415 
Prepaid expenses and other current assets                                            5,397            6,151
-----------------------------------------------------------------------------------------------------------
   Total current assets                                                            208,291          143,436

Long-term investments                                                               75,389           61,934
Property and equipment, net                                                         24,979           51,253
Goodwill and intangible assets, net                                                118,346          111,879
Other assets                                                                        21,940           17,173
-----------------------------------------------------------------------------------------------------------
   Total assets                                                              $     448,945     $    385,675
===========================================================================================================

Liabilities and Stockholders' Equity

Medical claims liabilities                                                   $     146,082     $     92,160
Accounts payable                                                                    11,919            9,164
Accrued payroll and benefits                                                        13,008           11,066
Other accrued liabilities                                                           59,636           27,686
Deferred revenue                                                                    14,888           13,880
Current portion of long-term debt                                                   36,468            2,307
-----------------------------------------------------------------------------------------------------------
   Total current liabilities                                                       282,001          156,263

Long-term debt                                                                      57,291           65,600
Other long-term liabilities                                                          9,226            7,994
Minority interest                                                                        -            1,967
Stockholders' equity:
         Common Stock, $.01 par value; 50,000,000 shares                           
         authorized; issued and outstanding, 33,001,296
         and 32,276,575 shares, respectively                                           330              323
         Additional paid-in capital                                                136,142          128,119
         Net unrealized investment gain                                                395              562
         Retained earnings (accumulated deficit)                                   (36,440)          24,847
-----------------------------------------------------------------------------------------------------------
         Total stockholders' equity                                                100,427          153,851
-----------------------------------------------------------------------------------------------------------
         Total liabilities and stockholders' equity                          $     448,945     $    385,675
===========================================================================================================
</TABLE>



See notes to consolidated financial statements.



                                      25
<PAGE>   28

Consolidated Statements of Operations
(in thousands, except per share data)

<TABLE>
<CAPTION>
                                                                                           Year Ended December 31,
-----------------------------------------------------------------------------------------------------------------------------
                                                                                    1996            1995             1994
-----------------------------------------------------------------------------------------------------------------------------
  <S>                                                                        <C>                <C>            <C>
  Operating revenues:
     Managed care premiums                                                   $     1,035,778    $    844,032   $      769,935
     Management services                                                              21,351           8,358            6,708
-----------------------------------------------------------------------------------------------------------------------------
        Total operating revenues                                                   1,057,129         852,390          776,643
-----------------------------------------------------------------------------------------------------------------------------

  Operating expenses:
     Health benefits                                                                 930,739         713,226          614,144
     Selling, general and administrative                                             165,081         123,523           94,684
     Depreciation and amortization                                                    42,862          14,666            9,437
     Other charges                                                                     9,793               -                -
     Merger costs                                                                          -           2,250            3,355
-----------------------------------------------------------------------------------------------------------------------------
        Total operating expenses                                                   1,148,475         853,665          721,620
-----------------------------------------------------------------------------------------------------------------------------

  Operating earnings (loss)                                                          (91,346)         (1,275)          55,023

  Other income, net                                                                   13,379           7,705            5,003
  Interest expense                                                                    (6,257)         (4,881)          (2,731)
-----------------------------------------------------------------------------------------------------------------------------
  Earnings (loss) before income taxes and minority interest                          (84,224)          1,549           57,295


  Provision for (benefit from) income taxes                                          (22,860)          1,530           24,426
  Minority interest in earnings (loss) of                                              
    consolidated subsidiary, net of income tax                                           (77)              1            3,581
-----------------------------------------------------------------------------------------------------------------------------
  Net earnings (loss)                                                        $       (61,287)   $         18    $      29,288
=============================================================================================================================

  Net earnings (loss) per common and common equivalent share                 $         (1.86)   $       0.00    $        0.93
=============================================================================================================================
  Weighted average common and common equivalent                                       
    shares outstanding                                                                33,011          32,164           31,425 
-----------------------------------------------------------------------------------------------------------------------------
</TABLE>

See notes to consolidated financial statements.


                                      26
<PAGE>   29




Consolidated Statements of Stockholders' Equity
Years Ended December 31, 1996, 1995 and 1994 (in thousands)

<TABLE>
<CAPTION>
                                                                                              Retained
                                                         Additional     Net Unrealized         Earnings            Total 
                                             Common       Paid-In         Investment         (Accumulated       Stockholders'  
                                             Stock        Capital        Gain  (Loss)          Deficit)            Equity         
                                            ---------------------------------------------------------------------------------
 <S>                                         <C>          <C>              <C>                <C>              <C>
  Balance, January 1, 1994                   $  293       $101,072         $         -        $ (4,459)        $    96,906

  Issuance of common stock,                      
   including exercise of options                 19          7,062                                                   7,081    
  Tax benefit of stock options                               
    exercised                                                1,653                                                   1,653
  Unrealized investment loss,                                                     
   net of income tax                                                              (804)                               (804)
  Net earnings                                                                                  29,288              29,288
--------------------------------------------------------------------------------------------------------------------------
  Balance, December 31, 1994                    312        109,787                (804)         24,829             134,124

  Issuance of common stock,                      
   including exercise of options                 
   and warrants                                  11         16,906                                                  16,917    
  Tax benefit of stock options                               
   exercised                                                 1,426                                                   1,426         
  Unrealized investment gain,                                                     
   net of income tax                                                             1,366                               1,366 
  Net earnings                                                                                      18                  18
--------------------------------------------------------------------------------------------------------------------------
  Balance, December 31, 1995                    323        128,119                 562          24,847             153,851

  Issuance of common stock,                       
   including exercise of options
   and warrants                                   7          5,739                                                   5,746
  Tax benefit of stock options                               
   exercised                                                 2,284                                                   2,284  
  Unrealized investment loss,                                                   
   net of income tax                                                              (167)                               (167)  
  Net loss                                                                                     (61,287)            (61,287)
--------------------------------------------------------------------------------------------------------------------------
  Balance, December 31, 1996                 $  330       $136,142         $       395        $(36,440)        $   100,427
==========================================================================================================================
</TABLE>


See notes to consolidated financial statements.


                                      27
<PAGE>   30

Consolidated Statements of Cash Flows
(in thousands)
<TABLE>
<CAPTION>
                                                                                      Year ended December 31,
--------------------------------------------------------------------------------------------------------------------
                                                                               1996            1995          1994
--------------------------------------------------------------------------------------------------------------------
 <S>                                                                      <C>             <C>             <C>
 Cash flows from operating activities of continuing operations:
     Net earnings (loss)                                                  $   (61,287)    $         18    $   29,288
     Adjustments to reconcile net income (loss) to cash                                                    
     provided by operating activities:
              Depreciation and amortization                                    42,862           14,666         9,437
              Benefit from deferred income taxes                              (15,989)          (2,029)         (657)
              Increase in receivable due to sale of subsidiary                 (5,500)               -             -
              Minority interest                                                   (19)               1         3,581
              Other                                                               103              (26)          386
     Changes in assets and liabilities of continuing                                         
     operations, net of effects of the purchase of 
     subsidiaries:
              Accounts receivable                                              (5,285)          (7,099)       (2,091)
              Other receivables                                                (6,749)          (4,913)       (1,969)
              Prepaid expenses and other current assets                           758             (582)        2,959   
              Other assets                                                     (5,652)          (6,458)       (1,563)
              Medical claims liabilities                                       49,350           21,736         4,849  
              Accounts payable                                                  2,742            4,374         1,331  
              Other accrued liabilities                                        32,781            9,205         9,112  
              Income taxes payable                                              6,315          (15,173)          686  
              Deferred revenue                                                    549           (3,756)          (36) 
              Other long-term liabilities                                       1,251            3,882         1,084  
                                                                                                                      
--------------------------------------------------------------------------------------------------------------------
 Net cash provided by operating activities of continuing operations            36,230           13,846        56,397
 Net cash used in operating activities of discontinued operations                   -                -          (542)
--------------------------------------------------------------------------------------------------------------------
 Net cash provided by operating activities                                     36,230           13,846        55,855
--------------------------------------------------------------------------------------------------------------------
 Cash flows from investing activities of continuing operations:                                            
     Capital expenditures, net                                                (12,688)         (16,319)      (22,466)
     Sales of investments                                                      75,511           53,224        41,109
     Purchases of investments & other                                         (80,049)         (64,193)      (55,841)
     Payments for purchases of subsidiaries, net of cash acquired             (27,256)          (2,524)      (54,279)
--------------------------------------------------------------------------------------------------------------------
 Net cash used in investing activities of continuing operations               (44,482)         (29,812)      (91,477)
 Net cash provided by investing activities of discontinued operations               -                -         8,809
--------------------------------------------------------------------------------------------------------------------
 Net cash used in investing activities                                        (44,482)         (29,812)      (82,668)
--------------------------------------------------------------------------------------------------------------------
 Cash flows from financing activities:                                                                     
     Borrowings of long-term debt                                              40,164           13,116        50,731
     Payments on long-term debt                                               (14,474)         (14,740)      (24,266)
     Net proceeds from issuance of stock                                        5,746           16,917         5,831
--------------------------------------------------------------------------------------------------------------------
 Net cash provided by financing activities                                     31,436           15,293        32,296
--------------------------------------------------------------------------------------------------------------------
 Net increase (decrease) in cash and cash equivalents                          23,184             (673)        5,483
 Cash and cash equivalents at beginning of period                              67,435           68,108        62,625
--------------------------------------------------------------------------------------------------------------------
 Cash and cash equivalents at end of period                               $    90,619     $     67,435    $   68,108
====================================================================================================================
====================================================================================================================
</TABLE>


See notes to consolidated financial statements.


                                      28
<PAGE>   31





Notes to Consolidated Financial Statements
Years Ended December 31, 1996, 1995 and 1994


A.  ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

         Coventry Corporation ("the Company") is a managed health care company
that provides comprehensive health benefits and services to employer groups and
government-funded groups in Pennsylvania, Ohio, West Virginia, Missouri,
Illinois, Virginia and Florida.

         The Company began operations in 1987 with the acquisition of the
American Service Companies ("ASC") entities.  In 1988, the Company acquired
HealthAmerica Pennsylvania, Inc. ("HAPA"), a Pennsylvania HMO.  In 1990, the
Company acquired Group Health Plan, Inc. ("GHP"), a St. Louis, Missouri HMO.

         Southern Health Services, Inc. ("SHS"), a Richmond, Virginia, HMO was
acquired by the Company in 1994. In 1995, the Company acquired HealthCare USA
("HCUSA"), a Jacksonville, Florida-based Medicaid managed care company.

         Principles of Consolidation - The consolidated financial statements
include the accounts of the Company and its subsidiaries.  All significant
intercompany transactions have been eliminated.

         Use of Estimates - The preparation of financial statements in
conformity with generally accepted accounting principles requires management to
make estimates and assumptions that affect the reported amounts of assets and
liabilities, disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during
the reporting period.  Actual results could differ from those estimates.

         Cash Equivalents - Cash equivalents consist principally of overnight
repurchase agreements, money market funds and certificates of deposit.  The
Company considers all highly liquid securities purchased with an original
maturity of three months or less to be cash equivalents.  The carrying amounts
of cash and cash equivalents reported in the accompanying consolidated balance
sheets approximate fair value.

         Investments - Effective January 1, 1994, the Company adopted
Statement of Financial Accounting Standards No.  115, "Accounting for Certain
Investments in Debt and Equity Securities" ("SFAS 115").  The Company considers
all of its investments as available for sale, and accordingly, records
unrealized gains and losses, net of deferred income taxes, as a separate
component of stockholders' equity.  Realized gains and losses on the sale of
these investments are determined on the basis of specific cost.  The adoption
of SFAS 115 did not have a material effect on the consolidated financial
statements.

         Investments with original maturities in excess of three months and
less than one year are classified as short-term investments and generally
consist of time deposits, U.S. Treasury Notes, and obligations of various
states and municipalities.  Long term investments have original maturities in
excess of one year and consist primarily of state and municipal debt securities
and obligations of the federal government and its agencies.

         Property and Equipment - Property and equipment are recorded at cost.
Depreciation is computed using the straight-line method over the estimated
lives of the related assets or, if shorter, over the terms of the respective
leases.

         Long-Lived Assets - Effective January 1, 1996, the Company adopted
Statement of Financial Accounting Standards Number 121 ("SFAS 121"),
"Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets
to be Disposed of."  Following the criteria set forth in SFAS 121, long-lived
assets to be held are reviewed by the Company for events or changes in
circumstances which would indicate that the carrying value may not be


                                      29
<PAGE>   32

recoverable.  In making this determination, the Company considers a number of
factors, including estimated future cash flows prior to interest and non-cash
expenses associated with the long-lived asset.  Assets held for sale are
recorded at the lower of the carrying amount or fair value, less any costs
associated with disposition.

         Goodwill and Intangible Assets - Goodwill and intangible assets
consist primarily of costs in excess of the fair value of the net assets of
subsidiaries or operations acquired which are amortized on a straight-line
basis over periods not exceeding 40 years.  Accumulated amortization of goodwill
and intangible assets was approximately $40.3 million and $9.4 million at
December 31, 1996 and 1995, respectively.  In accordance with SFAS 121, the
Company periodically evaluates the realizability of goodwill and intangible
assets and the reasonableness of the related lives in light of factors such as
industry changes, individual market competitive conditions, and operating
income trends (see Note B to Consolidated Financial Statements).

         Other Assets - Other assets consist of loan acquisition costs, assets
related to the supplemental executive retirement plan (Note M of the Notes to
Consolidated Financial Statements), investment in a limited partnership,
deferred charges and certain costs incurred to develop new service areas and
new products prior to the initiation of revenues.  Loan acquisition costs are
amortized over the term of the related debt while the other assets are
amortized over their expected periods of benefit, where applicable.  The
preoperational new service area and new product costs are amortized over the
expected benefit periods.  Accumulated amortization of other assets was
approximately $3.6 million and $4.6 million at December 31, 1996 and 1995,
respectively.

         Medical Claims Liabilities - Medical claims liabilities consist of
actual claims reported but not paid and estimates of health care services
incurred but not reported.  The estimated claims incurred but not reported are
based on historical data, current enrollment, health service utilization
statistics, and other related information.  These accruals are continually
monitored and reviewed, and as settlements are made or accruals adjusted,
differences are reflected in current operations.  Changes in assumptions for
medical costs caused by changes in actual experience could cause these
estimates to change in the near term.

         Revenue Recognition - Managed care premiums are recorded as revenue in
the month in which members are entitled to service.  Premiums collected in
advance are recorded as deferred revenue.  Employer contracts are typically on
an annual basis, subject to cancellation by the employer group or the Company
upon thirty days written notice.  Management services revenues are recognized
in the period in which the related services are performed.

         Reinsurance - Premiums paid to reinsurers are reported as health
benefits expense and the related reinsurance recoveries are reported as
deductions from health benefits expense.

         Income Taxes - The Company files a consolidated tax return for
Coventry and its wholly owned consolidated subsidiaries.  The Company accounts
for income taxes in accordance with Statement of Financial Accounting Standards
No. 109 ("SFAS 109").  The deferred tax assets and/or liabilities are determined
by multiplying the differences between the financial reporting and tax
reporting bases for assets and liabilities by the enacted tax rates expected to
be in effect when such differences are recovered or settled.  The effect on
deferred taxes of a change in tax rates is recognized in income in the period
that includes the enactment date.

         Minority Interest - For 1996, the minority interest represents a joint
venture interest of 51% in Pennsylvania HealthMate, Inc. ("HealthMate").  In
1995, the minority interest represents a minority shareholder's 30% interest in
HealthCare USA, Missouri LLC, a St. Louis-based Medicaid HMO.  The Company
purchased the remaining 30% effective January 1, 1996.  In 1994, the minority
interest represents a minority shareholder's 20% interest


                                      30
<PAGE>   33

in Penn Group Corporation (Penn Group), which owns 100% of HAPA.  On October
31, 1994, the Company purchased the Penn Group minority interest.

         Earnings Per Share - Earnings per share is computed based on the
weighted average shares of common stock and common stock equivalents
outstanding during the period.  Common stock equivalents arising from dilutive
stock options and warrants are computed using the treasury stock method.  Fully
diluted earnings per share are not presented as the calculation is either
antidilutive or does not materially affect earnings per share.

         SFAS no. 128, "Earnings per Share" has been issued effective for
fiscal years ending after December 15, 1997.  SFAS no. 128 establishes a new
standard for computing and presenting earnings per share.  The Company is
required to adopt the provisions of SFAS No. 128 in the fourth quarter of 1997
and does not expect adoption thereof to have a material effect on the Company's
financial position or results of operations.

         Reclassifications - Certain 1994 and 1995 amounts have been
reclassified to conform to the 1996 presentation.


B.       MERGERS AND ACQUISITIONS

         Effective July 28, 1995, the Company acquired HCUSA, a Jacksonville,
Florida-based managed care company.  Under the terms of the agreement,
2,849,691 shares of the Company's common stock, valued at approximately $45
million, were exchanged for all of HCUSA's capital stock in a nontaxable
transaction accounted for as a pooling of interests.  HCUSA operates a 26,000
member HMO in Jacksonville and northeastern Florida, and through a subsidiary
provides managed care services to Missouri Medicaid recipients.  At December
31, 1996, HCUSA's Missouri subsidiary had approximately 77,000 enrollees.  The
Company's financial statements have been restated to include the results of
HCUSA for all periods presented.

         Effective December 1, 1994, the Company acquired Southern Health
Management Corporation ("SHMC"), the parent company of SHS, a physician owned
HMO with approximately 45,000 members located in Richmond and central Virginia.
Under the terms of the agreement, common stock of the Company valued at
approximately $75 million was given as consideration in a nontaxable
transaction accounted for as a pooling of interests.  Each of SHMC's 833,757
outstanding shares of common stock was converted into 3.436 shares of the
Company's common stock resulting in 2,864,789 shares being issued.
Additionally, 42,500 outstanding options to acquire SHMC's common stock were
converted to options to acquire 146,030 shares of the Company's common stock.

         Accounting policies of the two companies were the same; therefore, no
conforming adjustments were needed.  No intercompany transactions existed
between the companies for the periods presented, and certain reclassifications
were made to SHMC's and HCUSA's financial statements to agree with Coventry's
presentation.

         In connection with the merger of SHMC, the Company recorded $3.4
million in the third and fourth quarters of 1994 for transaction costs. In
connection with the merger of HCUSA, the Company recorded $2.3 million of
merger costs in the second quarter of 1995.  These costs include expenses for
investments bankers, SEC filing and shareholder reporting fees and professional
fees.

         Effective March 22, 1996, the Company purchased 81% of the common
stock of PARTNERS Health Plan of Pennsylvania, Inc. ("PARTNERS") from a
subsidiary of Aetna Life & Casualty Company, now known as Aetna Services, Inc.
("Aetna") and acquired the remaining 19% of the common stock of PARTNERS
through the merger of a subsidiary of the Company with and into PARTNERS.
PARTNERS is the holding company for Coventry Health Plans of Western
Pennsylvania, Inc.  ("CHP"), which at the time of acquisition served
approximately 16,000 HMO members in the Pittsburgh area.  Consideration for the
transaction was approximately $35 million in cash, of which approximately $32.1
million was recorded as goodwill.  The acquisition has been accounted for under
the purchase method of accounting and,


                                      31
<PAGE>   34




accordingly, the net assets have been included in the consolidated financial
statements from the effective date of acquisition.  In conjunction with the
acquisition, the Company received a non-compete agreement from Aetna and
expected to enter into a favorable joint marketing agreement with Aetna and to
have the opportunity to acquire other Aetna membership at a favorable price.
These opportunities have not come to fruition and are not expected to, given
Aetna's acquisition of another competitor in the western Pennsylvania market.
As a result of these events, the Company filed suit against Aetna and the
competitor alleging breach of the acquisition agreement, seeking enforcement of
the non- compete agreement and requesting other forms of relief.  Based on the
current and future expected operating results, the Company has reduced the
carrying value of the goodwill to $10.0 million at December 31, 1996.

         Effective April 1, 1996 the Company entered into a Joint Venture
Agreement with Hamilton Health Center, Inc. to create HealthMate, Inc., 
a company providing health care services to Medicaid recipients in central
Pennsylvania. As part of the agreement the Company made an initial investment
of $300,000 for ownership of 49% of HealthMate's common stock and is obligated
under certain circumstances to make additional contributions totaling $550,000
over the next two and a half years.  As of April 1, 1996 HealthMate had
approximately 6,500 members.  The Company has accounted for this transaction
under the purchase method of accounting and, accordingly, the net assets have
been included in the consolidated financial statements from the effective date
of acquisition.

         Because the purchase price and the operations of the PARTNERS and
HealthMate acquisitions for the periods presented are not material to the
consolidated financial statements of the Company, pro forma financial
information has not been included herein.

         Effective January 1, 1996, the Company purchased the 30% minority
interest in HealthCare USA, Missouri LLC, a St. Louis-based Medicaid HMO.  The
purchase price was equal to the carrying value of the 30% ownership and as a
result, no goodwill was recorded.

         The Company purchased two physician group practices in Pennsylvania in
January 1995, and a third party administrator in Richmond, Virginia in May
1995.  The combined adjusted purchase price for these three acquisitions was
approximately $2.5 million, of which approximately $1.2 million was recorded as
goodwill.  The purchase price included approximately $600,000 related to
noncompete agreements which have been recorded as intangible assets in the
consolidated balance sheet and which will be amortized between four and ten
years.  In 1994, the Company purchased four physician group practices for which
the combined adjusted purchase price was $3.7 million.  Approximately $2.0
million of the combined purchase price related to noncompete agreements which
have been recorded as intangible assets and which will be amortized over
five to ten years.  Approximately $1.2 million of the combined purchase price
related to goodwill which will amortize over 25 years.  These acquisitions have
been accounted for under the purchase method of accounting and, accordingly,
the net assets have been included in the consolidated financial statements from
the effective dates of acquisition.  The transactions and operations of the
acquired entities are not significant in the consolidated financial statements
of the Company.

         Effective October 31, 1994, the Company purchased the then remaining
20% minority interest in Penn Group Corporation, the parent company of
HealthAmerica Pennsylvania, Inc., the Company's Pennsylvania HMO operations.
The purchase price was approximately $50 million in cash, of which
approximately $38.6 million was recorded as goodwill.



                                      32
<PAGE>   35



C.       OTHER CHARGES

         At the end of the second quarter of 1996, the Company established
reserves totaling $8.2 million for anticipated losses on multi-year contracts
with certain employer groups, primarily in the St. Louis market.  The Company
expects to utilize these reserves over the remaining lives of the contracts and
then either discontinue these products or significantly change the terms and
conditions of the contracts with these parties.  The contracts expire at
varying dates through 1999 and cover approximately 30,000 members.  In the
fourth quarter of 1996, the Company re-evaluated its position in relation to
the contracts and recorded additional reserves of $1.6 million.


D. PROPERTY AND EQUIPMENT

   Property and equipment is comprised of the following (in thousands):

<TABLE>
<CAPTION>
                                                       December 31,
--------------------------------------------------------------------------
                                                 1996             1995
--------------------------------------------------------------------------
<S>                                           <C>              <C>
Land                                          $       481      $     3,116
Buildings and leasehold improvements                8,427           25,507
Equipment                                          39,162           49,016
--------------------------------------------------------------------------
                                                   48,070           77,639
Less accumulated depreciation                     (23,091)         (26,386)
--------------------------------------------------------------------------
                                              $    24,979      $    51,253
==========================================================================
</TABLE>

         In February 1997, the Company announced the signing of agreements in
principle for the sale of its medical offices in St. Louis, Missouri and
Pittsburgh, Pennsylvania and definitive agreements for the sales of such
offices were signed in March 1997, subject to the satisfaction of various
conditions, including regulatory approval.  Accordingly, property and equipment
with a carrying value of approximately $23.9 million has been classified as a
current asset on the 1996 balance sheet.  The Company expects the net proceeds
from the sale will exceed the carrying value.

         In accordance with SFAS 121 (Note A of the Notes to Consolidated
Financial Statements), the Company determined that the carrying amounts of
certain of its property and equipment may not be recoverable as of December 31,
1996.  As a result, approximately $4.3 million of property and equipment
charge-offs were recorded in the fourth quarter of 1996.



                                      33
<PAGE>   36
E. INVESTMENTS IN DEBT AND EQUITY SECURITIES

         The Company considers all of its investments as available for sale 
securities, as defined within the Statement, and accordingly, records
unrealized gains and losses in the stockholders' equity section of its balance
sheet.  As of December 31, 1996 and 1995, stockholders' equity was increased by
approximately $0.4 million and $0.6 million, respectively, net of a deferred
tax cost of $0.1 million and $0.3 million, respectively, to reflect the net
unrealized investment gain on securities.  The amortized cost, gross unrealized
gain or loss and estimated fair value of short-term and long-term investments
by security type were as follows at December 31, 1996 and 1995 (in thousands):

<TABLE>
<CAPTION>
                                         Amortized           Unrealized      Unrealized      Fair
1996                                        Cost                Gain            Loss         Value
                                         ----------------------------------------------------------
<S>                                        <C>                  <C>            <C>          <C>
State and municipal bonds                  $50,926              $492           $    -       $51,418
Asset-backed securities                      9,407                 -              (31)        9,376
Mortgage-backed securities                  13,740                 -              (85)       13,655
US Treasury securities                       7,897                31                -         7,928
Other debt securities                          329                 -                -           329
Equity securities                               25                46                -            71
                                         ----------------------------------------------------------
                                           $82,324              $569           $ (116)      $82,777
                                         ==========================================================
</TABLE>
<TABLE>
<CAPTION>
                                          Amortized          Unrealized       Unrealized     Fair
1995                                         Cost               Gain             Loss        Value
                                          ----------------------------------------------------------   
<S>                                        <C>                  <C>                <C>      <C>
State and municipal bonds                  $59,892              $788               $-       $60,680
Asset-backed securities                      7,654                 -                -         7,654
Mortgage-backed securities                     526                 -                -           526
US Treasury securities                       9,517                74                -         9,591
Other debt securities                        1,815                 -                -         1,815    
Equity securities                               12                64                -            76    
                                          ----------------------------------------------------------   
                                           $79,416              $926               $-       $80,342    
                                          ==========================================================   
                                                                                                       
</TABLE>


                                      34
<PAGE>   37

         The amortized cost and estimated fair value of short-term and
long-term investments by contractual maturity were as follows at December 31,
1996 and December 31, 1995 (in thousands):

<TABLE>
<CAPTION>
                                                                                     Amortized        Fair
                                                                                       Cost           Value
 1996                                                                                ----------------------
 <S>                                                                                   <C>          <C>
 Maturities:
  Within 1 year                                                                       $ 7,366       $ 7,388
  1 to 5 years                                                                         26,140        26,229
  6 to 10 years                                                                         7,383         7,494
  Over 10 years                                                                        41,410        41,595
  Other securities without stated maturity                                                 25            71
                                                                                     ----------------------
  Total short-term and long-term securities                                           $82,324       $82,777
                                                                                     ======================
</TABLE>

<TABLE>
<CAPTION>
                                                                                      Amortized      Fair
                                                                                        Cost         Value
 1995                                                                                 --------------------
 <S>                                                                                  <C>           <C>
 Maturities:
  Within 1 year                                                                       $18,406       $18,408
  1 to 5 years                                                                         24,477        24,762
  6 to 10 years                                                                         6,344         6,424
  Over 10 years                                                                        30,177        30,672
  Other securities without stated maturity                                                 12            76
                                                                                      ---------------------
  Total short-term and long-term securities                                           $79,416       $80,342
                                                                                      =====================
</TABLE>

         Proceeds from the sale of investments were approximately $76 million
and $53 million for the twelve months ending December 31, 1996 and 1995,
respectively.  Gross investments gains of approximately $45,000 and gross
investments losses of $14,000 were realized on these sales for the twelve
months ended December 31, 1996 compared to $26,000 of gross investments gains
for the year ended December 31, 1995.  Realized gains and losses from securities
sales are determined on the specific identification of the securities.


F.  INCOME TAXES

         The provision (benefit) for income taxes attributable to earnings 
consisted of the following (in thousands):

<TABLE>
<CAPTION>
                                                                        Year Ended December 31,
 --------------------------------------------------------------------------------------------------------------
                                                           1996                  1995                  1994
 --------------------------------------------------------------------------------------------------------------
 <S>                                                  <C>                    <C>                   <C>
 Current provision (benefit):
   Federal                                            $     (6,181)          $     3,125           $     21,285
   State                                                      (690)                  434                  3,798


 Deferred provision (benefit):
   Federal                                                 (15,565)               (1,819)                  (558)
   State                                                      (424)                 (210)                   (99)
---------------------------------------------------------------------------------------------------------------
                                                      $    (22,860)          $     1,530           $     24,426 
===============================================================================================================
</TABLE>


                                      35
<PAGE>   38


         The expected tax provision (benefit) based on the statutory rate of 
35% differs from the Company's effective tax rate as a result of the following:


<TABLE>
<CAPTION>
                                                                               Year Ended December 31,
-----------------------------------------------------------------------------------------------------------
                                                                           1996         1995          1994
-----------------------------------------------------------------------------------------------------------
<S>                                                                      <C>           <C>          <C>
 Statutory federal tax rate                                              (35.00)%      35.00 %      35.00 %
 Effect of:
   State income taxes, net of federal benefit                             (1.40)%       9.40 %       5.71 %
   Amortization of goodwill                                               10.26 %      69.07 %       1.40 %
   Tax exempt interest income                                             (1.25)%     (75.37)%      (1.10)%
   Change in valuation reserve                                                  -            -      (1.42)%
   Merger costs                                                                 -      49.71 %       2.02 %
   Other                                                                   0.25 %      10.92 %       1.02 %
-----------------------------------------------------------------------------------------------------------
 Income tax provision (benefit)                                          (27.14)%      98.73 %      42.63 %
===========================================================================================================
</TABLE>


         The effect of temporary differences that give rise to significant
portions of the deferred tax assets and deferred tax liabilities at December
31, 1996 and 1995 are presented below (in thousands):


<TABLE>
<CAPTION>
                                                                                          December 31,
                                                                                    1996               1995
---------------------------------------------------------------------------------------------------------------
 <S>                                                                            <C>              <C>
 Deferred tax assets:

   Medical liabilities                                                          $        7,816   $          984
   Accounts receivable                                                                   2,897              904
   Provision for long-term contracts                                                     3,183                -
   Other accruals and deferred revenue                                                  10,943            6,234
   Net operating loss carryforward                                                       2,534              640
---------------------------------------------------------------------------------------------------------------
     Gross deferred tax assets                                                          27,373            8,762
     Less valuation allowance                                                             (911)            (640)
---------------------------------------------------------------------------------------------------------------
     Deferred tax asset                                                                 26,462            8,122
---------------------------------------------------------------------------------------------------------------
 Deferred tax liability:
   Property and equipment                                                                 (609)          (1,031)
   Capitalized development costs                                                        (1,806)            -
   Unrealized gain on securities available for sale                                       (128)            (363)
   Other                                                                                  (332)          (1,063)
---------------------------------------------------------------------------------------------------------------
     Gross deferred tax liabilities                                                     (2,875)          (2,457)
---------------------------------------------------------------------------------------------------------------
 Net deferred tax asset                                                         $       23,587   $        5,665
===============================================================================================================
</TABLE>

         The valuation allowance for deferred tax assets as of December 31,
1996 was $0.9 million due to the Company's belief that the realization of the
deferred tax asset resulting from federal and state net operating loss
carryforwards associated with certain acquisitions is doubtful.  The valuation 
allowance provided at December 31, 1996 will be allocated to reduce goodwill and
other intangible assets if the realization of the acquired net operating loss
carryforwards becomes more likely than not.



                                      36
<PAGE>   39

G. NOTES PAYABLE AND LONG-TERM DEBT

         Long-term debt consists of the following (in thousands):

<TABLE>
<CAPTION>
                                                                                      December 31,
                                                                                   1996          1995
  <S>                                                                            <C>            <C>
  Borrowings under the Credit Facility                                            $90,000       $62,000
  Note payable to U.S. DHHS                                                         1,762         2,303
  Other notes payable                                                               1,997         3,604
                                                                                 ----------------------
                                                                                   93,759        67,907
  Less current portion of long-term debt                                          (36,468)       (2,307)
                                                                                 ----------------------
  Total long-term debt                                                            $57,291       $65,600
                                                                                 ======================
</TABLE>

         Prior to June 30, 1996, the Company's long-term credit agreement (the
"Credit Facility") with a group of banks provided a reducing revolving line of
credit of $125 million, collateralized by substantially all of the Company's
assets.  The Credit Facility originally called for scheduled semi-annual
commitment reductions totaling $20.8 million beginning February 18, 1997 and
terminating availability on August 18, 1999. As of June 30, 1996, the Company
was not in compliance with certain financial covenants in the Credit Facility.
Effective September 30, 1996, the Company reached an agreement ("Amended Credit
Facility") with the bank group amending the Credit Facility.  Prior to the 
amendment, the Company voluntarily reduced the availability under the Credit
Facility to $100 million. The Amended Credit Facility, along with other
changes, revised certain financial ratios that the Company was required to
maintain, increased the interest rate on the indebtedness by 0.8% and revised
the required reductions in availability. At December 31, 1996, the effective
interest rate on indebtedness under the Amended Credit Facility was 7.56%.

         As of December 31, 1996, the Company was not in compliance with
certain revised financial covenants in the Amended Credit Facility.  
Subsequent to December 31, 1996, the Company entered into an amended and
restated agreement ("Restated Credit  Facility") with the bank group  effective
March 28, 1997, that along with other changes, converts the amount outstanding
under the Restated Credit Facility to a term loan, revises certain financial
ratios the Company is required to maintain, effectively increases the interest
rate on the indebtedness by 2.7% and revises the amortization period of the
loan.  The Restated Credit Facility requires payments of $10 million  on June
30, 1997, $7 million on September 30, 1997, $18 million on December 31, 1997
and $55 million on April 1, 1998.  The Restated Credit Facility eliminated the
defaults that existed under the Amended Credit Facility at December 31, 1996. 
Obligations under the Restated Credit Facility will bear interest at a rate
equal to the higher of the prime rate plus 2.0% or the federal funds rate plus
2.5%.

         The Restated Credit Facility requires the Company to apply 50% of the 
net cash proceeds of sales of the Company's equity securities to reduce the
scheduled amortizations, prohibits the sale  of any substantial subsidiary and
restricts the Company's ability to declare  and pay cash dividends on its
common stock.    

         The  Restated Credit Facility contains covenants relating to net worth,
investments in non-admitted assets, operating margins and the creation or 
assumption of debt or liens on the assets of the Company. Prior to the closing
of the proposed Warburg transactions described in Note S, a material adverse
change in the Company's financial condition or results of operations will
constitute an event of default under the Restated Credit Facility. The Restated
Credit Facility is collaterlized by substantially all of the assets of the
Company.

         On March 31, 1997 the effective interest rate on the indebtedness
under the Restated Credit Facility was 10.5%.

         Notes payable to the U. S. Department of Health and Human Services
("U.S. DHHS") represents obligations which were assumed in the acquisition of
HAPA.  Under the terms of the notes, principal is payable in various annual
installments through June 30, 2000 with interest payable semi-annually at rates
ranging from 7.75% to 9.125%.  The notes are secured by certain assets of the
Company.

         Other notes payable relate primarily to the acquisition of two
physician group practices in 1995 and four in 1994  (see Note D of the Notes to
Consolidated Financial Statements).  Under the terms of these acquisitions, a
portion of the total purchase price is deferred for terms ranging between two
and four years.  These deferred payments do not accrue interest.


                                      37
<PAGE>   40


         Maturities of long-term debt during each of the ensuing five years
ending December 31 and thereafter are as follows (in thousands):

<TABLE>
                   <S>                                    <C>
                      1997                                $ 36,468
                      1998                                  56,210
                      1999                                     687
                      2000                                     376
                      2001                                      18
                   Thereafter                                    -
                                                          --------
                                                          $ 93,759
                                                          ========
</TABLE>


H. STOCK DIVIDEND

         On August 3, 1994, the Company's Board of Directors approved a
two-for-one stock split in the form of a stock dividend with one additional
share of common stock issued for every share held by shareholders of record as
of July 20, 1994.  All share and per share amounts for 1994 have been adjusted 
to reflect the stock split.


I.       STOCK OPTIONS, WARRANTS AND EMPLOYEE STOCK PURCHASE PLAN

         As of December 31, 1996, the Company had five stock option plans for
issuance of common stock to key employees, including physicians and directors.
Under these plans, the exercise provisions and prices of the options are
established on an individual basis with the exercise price of the options
generally being equal to 100% of the market value of the underlying stock at
the date of grant.  Options generally become exercisable after one year in
20-25% increments per year and expire ten years from the date of grant.  The
plans provide for incentive or nonqualified stock options to be issued at the
discretion of the Board of Directors.

         With the merger of SHMC in December 1994, the Company assumed SHMC's
incentive stock option plan.  The Company issued options for 146,030 shares of
common stock in exchange for 42,500 options to acquire shares of SHMC common
stock granted under SHMC's incentive stock option plan.  These options were
exercisable upon the completion of the merger with SHMC and expire in 2003.

         With the merger of HCUSA in July 1995, the Company exchanged 2,849,691
shares of the Company's common stock for all of HCUSA's common stock, preferred
stock and stock options.

         Transactions with respect to the plans for the three years ended
December 31, 1996 were as follows and have been restated to reflect the
two-for-one stock split in the form of a stock dividend in August 1994:

<TABLE>
<CAPTION>
                                                                         Number of            Option Price
                                                                          Shares                Per Share
-----------------------------------------------------------------------------------------------------------------
 <S>                                                                    <C>               <C>             <C>

 Outstanding at January 1, 1994                                          1,732,430        $ 1.275  -      $21.250
 Granted                                                                   588,850        $16.875  -      $25.000
 Exercised                                                                (284,820)       $ 1.275  -      $13.563
 Canceled                                                                  (93,000)       $ 4.750  -      $21.250
-----------------------------------------------------------------------------------------------------------------
 Outstanding at December 31, 1994                                        1,943,460        $ 3.780  -      $25.000

 Granted                                                                   716,750        $15.875  -      $24.500
 Exercised                                                                (246,668)       $ 3.780  -      $21.250
 Canceled                                                                 (169,000)       $ 5.000  -      $24.250
-----------------------------------------------------------------------------------------------------------------
 Outstanding at December 31, 1995                                        2,244,542        $ 3.780  -      $25.000

 Granted                                                                 2,891,589        $ 9.625  -      $20.625
 Exercised                                                                (450,224)       $ 3.780  -      $18.125
 Canceled                                                               (1,823,489)       $ 5.000  -      $25.000
-----------------------------------------------------------------------------------------------------------------
 Outstanding at December 31, 1996                                        2,862,418        $ 3.780  -      $25.000
=================================================================================================================
</TABLE>


                                      38
<PAGE>   41

         Options vested and exercisable at December 31, 1996, 1995 and 1994
were 740,017, 888,573 and 664,266, respectively.

         At December 31, 1996, the Company had outstanding warrants granting
holders the right to purchase 100,000 shares of common stock.  The 100,000
warrants were issued in July 1995 at a price of $14.125 and expire July 2000.
Warrants were issued in December 1993 granting holders the right to purchase
800,000 shares at an exercise price of $21.00.  Of the 800,000 shares, 550,300
were exercised before the expiration in December 1995.  The remaining 249,700
warrants expired in December 1995.  During the first half of 1996, 170,000
warrants were exercised at a price of $6.75.

         At various dates in 1996, the Company repriced, canceled and reissued
approximately 1.3 million shares under option.  The options canceled were at
prices ranging from a high of $25.00 to a low of $15.63.  The shares were
reissued at market on the date of reissue and the prices ranged from a high of
$18.13 to a low of $12.75.

         As of December 31, 1996, the Company had reserved an aggregate of
approximately 3.3 million common shares for options and warrants, approximately
0.4 million of which are available for future grants.

         The Company implemented an Employee Stock Purchase Plan in 1994 which
allows substantially all employees who meet length of service requirements to
set aside a portion of their salary for the purchase of Company stock.  At the
end of each plan year, the Company will issue the stock to participating
employees at an issue price equal to 85% of the lower of the stock price at the
end of the plan year or the average stock price, as defined.  The Company has
reserved 1.0 million shares of stock for this plan and has issued 13,267 and
19,465 shares in 1995 and 1996, respectively, under this plan.

         In 1995, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards Number 123 ("SFAS 123"), "Accounting for
Stock-Based Compensation."  SFAS 123 establishes new financial accounting and
reporting standards for stock-based compensation plans.  The Company has
adopted only the disclosure requirements of SFAS 123.  As a result, no
compensation cost has been recorded for the Company's stock option plans.  In
addition, based on the number of options outstanding and the historical and
extrapolated future trends of factors affecting valuation of those options,
management has determined that any compensation cost attributable to options
granted is immaterial.


J.       REINSURANCE

         The Company has reinsurance agreements, through its subsidiary CHLIC,
with a major insurance company for portions of the risk it has underwritten
through its products.  In 1996, commercial HMO risk was reinsured to $500,000
per member per year in excess of a maximum loss retention of $500,000 per
member per year and 20% coinsurance, subject to certain limits on hospital
costs per patient-day.  PPO risk was reinsured to $850,000 per member per year
in excess of maximum loss retention of $150,000 per member per year and 20%
coinsurance.  Medicaid in Florida and Pennsylvania was reinsured to $950,000
per member per year in excess of a maximum loss retention of $50,000 per member
per year and 20% coinsurance.

         Medicaid risk in Missouri was reinsured through the state of Missouri
mandated program with retention of $50,000 per member per year and 20%
coinsurance.  Medicare risk was reinsured $850,000 per member per year in
excess of a maximum loss retention of $150,000 per member per year and 20%
coinsurance.


                                      39
<PAGE>   42





         Reinsurance premiums for the years ended December 31, 1996, 1995 and
1994, were approximately $1.8 million, $2.8 million and $3.3 million,
respectively.  Reinsurance recoveries for the same periods were approximately
$1.5 million, $0.9 million and $1.3 million.


K. COMMITMENTS

   The Company operates primarily in leased facilities with original lease
terms ranging from two to fifteen years.  The Company also leases computer
equipment with lease terms of approximately three years.  Leases that expire
generally are expected to be renewed or replaced by other leases.

   The minimum rental commitments payable by the Company during each of the
next five years ended December 31 and thereafter for noncancellable operating
leases are as follows (in thousands):

<TABLE>
<CAPTION>
             Year                                             Amount
            -----                                             ------
          <S>                                               <C>
             1997                                           $  9,690
             1998                                              7,859
             1999                                              5,841
             2000                                              4,368
             2001                                              3,484
                                                            --------
          Thereafter                                          12,750
                                                            --------
                                                            $ 43,992
                                                            ========
</TABLE>

         Total rent expense was approximately $11.7 million, $10.5 million and
$10.6 million for the years ended December 31, 1996, 1995, and 1994,
respectively.  

         As a result of premium rate reductions in Florida in 1995 and the
commercial membership requirements, the Company has determined that its Florida 
Medicaid operations are unlikely to be sufficiently profitable on a long-term
basis to justify a continued presence in the Florida market and, as a result,
the Company is considering various options concerning this business, with the
long-term goal of exiting the Florida Medicaid market if premium rates are not
increased.  Accordingly, the Company has established a reserve of $1.2 million
at December 31, 1996 to reflect the anticipated costs of exiting this market.


L.       CONCENTRATIONS OF CREDIT RISK

         Financial instruments which potentially subject the Company to
concentrations of credit risk consist primarily of cash and cash equivalents,
investments in marketable securities and premiums receivable.  The Company
invests its excess cash in interest bearing deposits with major banks,
commercial paper and money market funds.  Investments in marketable securities
are managed within guidelines established by the Board of Directors which
emphasize investment-grade fixed income securities and limit the amount that
may be invested in any one issuer.  The fair value of the Company's financial
instruments is substantially equivalent to their carrying value and, although
there is some credit risk associated with these instruments, the Company
believes this risk to be minimal.

         As discussed in Note S to Consolidated Financial Statements, the
Company will enter into long-term global capitation arrangements with two
integrated provider organizations.  To the extent that the Company becomes a 
party to global capitation agreements with a single provider organization
serving substantial membership, the Company becomes exposed to credit risk with
respect to such organizations.

         As of December 31, 1996, the western Pennsylvania, central
Pennsylvania, St. Louis, Richmond and HCUSA subsidiaries comprised 37%, 16%,
17%, 2% and 28% of accounts receivable, respectively.  The Company's largest
employer group, the U.S. Office of Personnel Management, accounted for
approximately 5% of the Company's managed care



                                      40
<PAGE>   43

premiums in 1996 and approximately 14% of the accounts receivable at December
31, 1996.  The Company believes the allowance for doubtful collections
adequately provides for estimated losses as of December 31, 1996.  The Company
has a risk of incurring loss if such allowances are not adequate.


M. BENEFIT PLANS

         On July 1, 1994, the Company adopted an employee retirement plan
qualifying under IRC Section 401(k), the Coventry Corporation Retirement
Savings Plan (the "Plan"), which covers substantially all employees of the
Company and its subsidiaries who meet certain requirements as to age and length
of service and who elect to participate in the Plan.  Similar retirements
savings plans offered by (1) both  HAPA and GHP and (2) both CHMC and HCUSA
were merged into the Plan effective July 1, 1994 and January 1, 1996,
respectively.  Under the Plan, employees may defer up to 15% of their
compensation, limited by the maximum compensation deferral amount permitted by
applicable law.  The Company makes matching contributions equal to 100% of the
employee's contribution on the first 3% of the employee's compensation deferral
and equal to 50% of the employee's contribution on the second 3% of the
employee's compensation deferred.  Employees vest in the Company's matching
contributions in 20% increments annually over a period of 5 years, based on
length of service with the Company and/or its subsidiaries.  All costs of the
Plan are funded by the Company as they are incurred.

         On July 1, 1994, the Company adopted a supplemental executive
retirement plan (the "SERP"), which covers employees of the Company and its
subsidiaries who (1) meet certain requirements as to age and management
responsibilities and/or salary, (2) are designated as being eligible to
participate in the SERP by the Compensation and Benefits Committee of the Board
of Directors of the Company, and (3) elect to participate in the SERP and the
Plan.  A similar supplemental executive retirements plan offered by HAPA was
merged into the SERP effective July 1, 1994.  Under the SERP, employees may
defer up to 15% of their base salary, and up to 100% of any bonus awarded, over
and beyond the compensation deferral limits of the Plan.  The Company makes
matching contributions equal to 100% of the employee's contribution on the
first 3% of the employee's compensation deferred and 50% of the employee's
contribution on the second 3% of the employee's compensation deferred.
Employees vest in the Company's matching contributions in 20% increments
annually over a period of 5 years, based on length of service with the Company
and/or its subsidiaries.  All costs of the SERP are funded by the Company as
they are incurred.

         The cost, principally employer matching contributions, of the benefit
plans charged to operations for the years 1996, 1995 and 1994 was approximately
$2.4 million, $3.1 million and $3.5 million, respectively.



                                      41
<PAGE>   44
N.       STATUTORY INFORMATION

         The Company's HMO subsidiaries are required by the respective domicile
states to maintain minimum statutory capital and surplus in the aggregate of
approximately $14.0 million at December 31, 1996.  Combined statutory capital
and surplus of the Company's HMO was approximately $27.9 million.  The states
in which the Company's HMOs operate require the HMOs to maintain deposits with
the Department of Insurance.  At December 31, 1996, these deposits totaled $2.8
million and are included as other long-term assets in the financial statements.

         CHLIC is required to maintain minimum statutory capital and surplus of
approximately $3.0 million.  Statutory capital and surplus of CHLIC as of
December 31, 1996 was approximately $30.7 million.  Statutory deposits for
CHLIC as of December 31, 1996 totaled approximately $3.7 million.


O.  OTHER INCOME

         Other income for the years ended December 31, 1996, 1995, and 1994
includes investment income of approximately $8.4 million, $7.4 million, and
$5.0 million, respectively.  Additionally, in the fourth quarter of 1996, other
income includes a non-recurring gain of approximately $4.9 million as a result
of the sale of Champion Dental Service, Inc.


P.       SUPPLEMENTAL DISCLOSURES OF CASH FLOW

         Cash paid during the periods for interest and income taxes is as
follows (in thousands):

<TABLE>
<CAPTION>
                                              Year ended December 31,
---------------------------------------------------------------------------
                                       1996         1995             1994
---------------------------------------------------------------------------
<S>                                   <C>          <C>              <C>
Interest                              $ 5,862      $ 4,517          $ 2,491
Income taxes                          $ 1,309      $16,410          $19,240
</TABLE>


Q.  DISCONTINUED OPERATIONS

         On March 30, 1992, the Company's Board of Directors approved a plan
pursuant to which the Company discontinued certain operations of ASC.  ASC
provided individually underwritten health care benefits coverage to
self-employed individuals or small employers through CHLIC.  The Company
retains CHLIC insurance licenses in 43 states and CHLIC continues to underwrite
the indemnity portion of certain flexible provider products offered by the
Company's HMOs.

         Effective December 1, 1992, the Company entered into an agreement with
United Insurance Companies, Inc. ("United"), whereby United assumed management
responsibility for the discontinued operations; accordingly, the small-group
policies remaining in force comprised a closed book of business.  Effective
January 1, 1995, United assumption reinsured the ASC closed book of business.
Under the terms of the agreement, United assumed substantially all of the
closed book of business claims, unearned premium reserves, and all other
statutory liabilities, except for certain litigation reserves that are retained
by the Company.



                                      42
<PAGE>   45
R. LEGAL PROCEEDINGS

         In the normal course of business, the Company has been named as
defendant in various legal actions seeking payments for claims denied by the
Company, medical malpractice, and other monetary damages.  The claims are in
various stages of proceedings and some may ultimately be brought to trial.
Incidents occurring through December 31, 1996 may result in the assertion of
additional claims.  With respect to medical malpractice, the Company carries
professional malpractice and general liability insurance for each of its
operations on a claims made basis with varying deductibles for which the
Company maintains reserves.  In the opinion of management, the outcome of these
actions will not have a material adverse effect on the financial position or
results of operations of the Company.


S.       SUBSEQUENT EVENTS

         In March 1997, the Company entered into agreements to sell the medical
offices associated with Group Health Plan, its health plan in St. Louis,
Missouri and HealthAmerica, its health plan in Pittsburgh, Pennsylvania, to
major healthcare provider organizations in these markets.  The purchase price
is $27 million in cash for the St. Louis medical offices and $20 million in
cash for the Pittsburgh offices. The initial agreements cover medical offices
serving 92,000 members at Group Health Plan and 80,000 members at
HealthAmerica.  The agreements are subject to the satisfaction of various
conditions, including regulatory approval.  Coincident with the sale of the
medical offices, the Company will enter into long-term global capitation
arrangements with the purchasers of the medical offices, pursuant to which the
provider organizations will receive a fixed percentage of premiums to cover all
the medical treatment the Company's globally capitated members receive from
the health care systems.  The transactions are expected to occur in the first
half of 1997 and therefore, the assets of the respective medical offices have
been classified as current assets as of December 31, 1996. The anticipated
proceeds from the transactions are expected to exceed the current carrying
value of the medical offices.

         On March 17, 1997, the Company announced that it entered into a
letter of intent with Warburg, Pincus Ventures, L.P. ("Warburg") for Warburg's
purchase of $40 million of Convertible Exchangeable Subordinated Notes of the
Company, together with warrants to purchase 2.35 million shares of the
Company's common stock.  The notes are expected to be convertible into 4
million shares of the Company's common stock.  The investment by Warburg is
subject to the negotiation of definitive terms, the approval of state
insurance regulators in certain states, and the approval of the lending banks
under the Credit Facility.  The notes will be exchangeable at the Company's
option for shares of convertible preferred stock, the authorization of which
will require the approval of the Company's shareholders at the 1997
shareholders' meeting.  If the proposed Convertible Notes transaction is not
consummated, the Company will likely seek alternative financing in order to
meet scheduled debt service obligations.


                                      43
<PAGE>   46




T. QUARTERLY FINANCIAL DATA (unaudited)

         The following is a summary of unaudited quarterly results of
operations (in thousands, except per share data) for the years ended December
31, 1996 and 1995.

<TABLE>
<CAPTION>
                                                                                   Quarter Ended

                                                            March 31,         June 30,        September 30,      December 31,
                                                             1996(1)           1996(2)            1996              1996(3)
                                                           ------------------------------------------------------------------
 <S>                                                       <C>              <C>              <C>                 <C>
 Operating revenues                                        $ 236,937        $ 257,737        $  272,903          $ 289,552
 Operating earnings (loss)                                 $  (2,772)       $ (14,346)       $      143          $ (74,371)
 Net earnings (loss)                                       $    (968)       $  (8,528)       $      348          $ (52,139)
 Net earnings (loss) per common
  and common equivalent share                              $   (0.03)       $   (0.26)       $     0.01          $   (1.58)
                                                           ------------------------------------------------------------------
 Weighted average common and common
  equivalent shares outstanding                               32,854           33,041            33,021             33,024
                                                           ------------------------------------------------------------------
</TABLE>

<TABLE>
<CAPTION>
                                                                                  Quarter Ended

                                                            March 31,        June 30,         September 30,      December 31,
                                                              1995           1995(4)            1995(5)            1995(6)
                                                           -----------------------------------------------------------------
 <S>                                                       <C>              <C>               <C>                <C>
 Operating revenues                                        $ 209,652        $ 208,868         $ 211,137          $ 222,733
 Operating earnings (loss)                                 $  16,253        $   4,764         $   1,118          $ (23,410)
 Net earnings (loss)                                       $   9,870        $   2,177         $   1,494          $ (13,523)
 Net earnings (loss) per common and common                 
   equivalent share                                        $    0.30        $    0.07         $    0.05          $   (0.42) 
                                                           -----------------------------------------------------------------
 Weighted average common and common equivalent                
   shares outstanding                                         32,402           32,157            31,952             32,416    
                                                           =================================================================
</TABLE>

(1)  The first quarter operating results were affected by termination and 
     related costs to streamline the Company's administrative process and reduce
     staffing in health centers, primarily in the Pennsylvania and St. Louis 
     plans for total adjustments of $5.2 million.

(2)  The second quarter operating results were affected by the establishment 
     of reserves relating to multi-year contracts with certain employer groups,
     primarily in the St. Louis market.  The Company expects to utilize these
     reserves over the remaining lives of the contracts and then either 
     discontinue the contracts or significantly change the terms and conditions 
     of the contracts with these parties.  The establishment of these reserves
     resulted in total adjustments of $8.2 million.

(3)  The fourth quarter operating results were affected by the increase of 
     reserves related to accounts receivable ($3.6 million), long-term contracts
     ($1.6 million), medical claims ($25.6 million), termination costs 
     ($2.1 million), other reserves ($6.0 million), write-offs of goodwill 
     ($21.0 million) and certain capitalized expenses ($6.7 million).

(4)  The second quarter operating results of 1995 were affected by merger 
     costs for the purchase of HCUSA, severance and related costs associated 
     with staff restructuring in Pittsburgh and St. Louis, additions to 
     accruals for professional liability litigation and the settlement of 
     certain Office of Personnel Management negotiations for total adjustments 
     of approximately $7.0 million.

(5)  The third quarter operating results of 1995 were affected by an increase 
     in medical claims liabilities for the western Pennsylvania market and 
     start up expenses associated with Medicaid and Medicare product 
     development and geographic expansion initiatives for total adjustments of
     approximately $6.5 million.

(6)  The fourth quarter operating results of 1995 were affected by the 
     elimination of several of its new market development areas, personnel 
     reductions in the operations and increases in legal, medical and 
     contingency reserves for total adjustments of $21.8 million.



                                      44
<PAGE>   47





Item 9:          Changes in and Disagreements with Accountants on Accounting
                 and Financial Disclosure

         None.








                                      45
<PAGE>   48





                                    PART III


Item 10:   Directors and Executive Officers of the Registrant
 
     The Company's directors and executive officers are as follows:
 
<TABLE>
<CAPTION>
NAME                            AGE                        POSITION
----                            ---                        --------
<S>                             <C>   <C>
John H. Austin, M.D...........  52    Director(1)(2)
Philip N. Bredesen............  53    Director
Laurence DeFrance.............  52    Director(1)(2)
Emerson D. Farley, Jr., M.D...  58    Director
Richard H. Jones..............  41    Director, Senior Vice President, Finance and
                                        Development
Lawrence N. Kugelman..........  54    Director
Allen F. Wise.................  54    Director, Chief Executive Officer and President
Joseph N. Carroll.............  58    Vice President of Operations
Raul Coronado, M.D., M.S......  58    Vice President and Medical Director
Christopher T. Fey............  45    Vice President
James L. Gore.................  59    Vice President
James R. Hailey...............  40    Vice President, Specialty Markets
Jan H. Hodges.................  37    Vice President, Finance
Nancy I. Lorenz...............  49    Vice President, Government Programs
George R. Mark................  36    Vice President
Robert A. Mayer...............  54    Senior Vice President
Frederick G. Merkel...........  43    Regional Vice President
Thomas J. Murray..............  51    Vice President
Shirley R. Smith..............  52    Vice President, Corporate General Counsel and
                                        Secretary
Dale B. Wolf..................  43    Senior Vice President, Chief Financial Officer and
                                        Treasurer
</TABLE>
 
---------------
 
(1) Member of Compensation and Benefits Committee
(2) Member of Audit and Finance Committee
 
     Dr. Austin has been a director of the Company since January 1988 and was
elected Chairman of the Board of Directors in December 1995. From October 1994
to March 1997, he served as President of the Professional Services Division of
Unihealth, one of the nation's largest voluntary non-profit healthcare networks.
From July 1992 to October 1994 he was a self-employed healthcare consultant. He
was employed as Executive Vice President and Medical Director for Health Plan of
America, a health maintenance organization ("HMO"), from 1987 until June 1992.
 
     Mr. Bredesen accepted a position as a director of the Company in April
1997. He was formerly a director of the Company from its founding in November
1986 to January 1993. He is currently the Mayor of the Metropolitan Government
of Nashville and Davidson County, Tennessee, having been elected to that
position in August 1991 and re-elected in August 1995.
 
     Mr. DeFrance has been a director of the Company since August 1990. He is
currently self-employed. He was a member of the Board of Directors of
DeVlieg-Bullard, Inc., a manufacturer of precision engineered machine tools,
from April 1986 to December 1994. He was DeVlieg-Bullard's President from April
1986 to March 1992 and its Chief Executive Officer from December 1989 to March
1992.
 
     Dr. Farley has been a director of the Company since December 1994. Dr.
Farley founded Medical Specialists, Inc., a multi-specialty internal medicine
group located in Richmond, Virginia, in 1972, and has been a practicing member
of that group since its inception. Since 1989 he has been the Medical Consultant
for Signet Bank in Richmond, Virginia. From 1984 to 1994, he was the Chairman of
the Board of Directors of Southern Health Management Corporation (now known as
Coventry HealthCare Management Corporation).
 
     Mr. Jones has been a director of the Company since December 1995. A
certified public accountant, Mr. Jones was named President and Chief Executive
Officer of Group Health Plan, Inc. on October 7, 1996. He is
 
                                      46
<PAGE>   49
 
also Senior Vice President, Finance and Development of the Company and was
Treasurer of the Company from June 1993 until December 1996. From November 1990
to June 1993, he was Vice President, Chief Financial Officer and Treasurer of
the Company.
 
     Mr. Kugelman has been a director of the Company since August 1992. He was
interim Chief Executive Officer and President of the Company from December 1995
until October 6, 1996. From March 1995 until December 1995 he was a
self-employed healthcare consultant. He was Executive Vice President of American
Medical International, an organization that owns and operates acute care
hospitals nationwide, from January 1993 to March 1995. From July 1992 to
December 1992, he was Executive Director of the Sisters of St. Joseph Healthcare
Foundation, which was created in connection with HealthPlan of America's
conversion from not-for-profit to for-profit status. He was President and Chief
Executive Officer of Health Plan of America from September 1986 to July 1992.
 
     Mr. Wise was elected a director of the Company in October 1996. He was
named President and Chief Executive Officer of the Company on October 7, 1996.
He was Executive Vice President of MetraHealth Company, Inc. from October
1994 until it was acquired by United HealthCare Corp. in October 1995 and was
Executive Vice President of United HealthCare Corp. from October 1995 until
October 1996.  From January 1994 to October 1994 he was President and Chief
Executive Officer of Wise Health System, a healthcare investment company. From
1991 to 1994, Mr. Wise was President and Chief Executive Officer of Keystone
Health Plan, a managed healthcare company, and was also Chief Operating Officer
of Independence Blue Cross, a healthcare insurance company located in
Philadelphia, Pennsylvania.

     Dr. Coronado was elected Vice President and Medical Director of the
Company on April 16, 1997 and has served as Vice President and Chief Medical
Officer of the Company's subsidiary HealthCare USA-Missouri, LLC since July
1996. From 1995 to June 1996, Dr. Coronado was the Chief Medical Officer for
Harmony Health Plan, a West Orange, New Jersey HMO and from 1994 to 1995 he was
the Chief Medical Officer of The Prudential Insurance Company/Prucare, an
insurance company located in Suffren, New York. From 1993 to 1994, Dr. Coronado
was the Medical Director for Fidelis Care, a Medicaid managed healthcare plan
located in Brooklyn, New York. From 1988 to 1993, Dr. Coronado was the
Associate Medical Director for US HealthCare, Inc., an HMO company located in
Blue Belle, Pennsylvania, and also maintained a private family medical practice
in Summit and Morristown, New Jersey.   
 
     Mr. Carroll was elected Vice President of Operations of the Company on
October 14, 1996. From April 1996 to October 1996, he was a self-employed
healthcare consultant. From March 1992 to April 1996, Mr. Carroll was the Senior
Vice President and Chief Information Officer of Independence Blue Cross, a
healthcare insurance company located in Philadelphia, Pennsylvania.
 
     Mr. Fey has been a Vice President of the Company since September 1995.
Since 1992 he has been Chief Executive Officer of HealthCare USA, Inc. From 1992
to November 1995 and from March 20, 1996 to the present he has been President of
HealthCare USA, Inc. From 1990 to 1992, Mr. Fey was President of Healthcare
Communication Services, Inc., a healthcare consulting and publishing company
located in Gainesville, Florida.
 
     Mr. Gore has been a Vice President of the Company since December 1994.
Since 1990 he has been President and Chief Executive Officer of Coventry
HealthCare Management Company and its two subsidiaries, Southern Health Benefit
Services, Inc., a third party claims administrator for claims processing, and
Southern Health Services, Inc., a 57,000 member open panel HMO located in
Richmond, Virginia.
 
     Mr. Hailey has been the Vice President, Specialty Markets, of the Company
since March 1994. Prior to joining the Company, Mr. Hailey was employed by
SmithKline Beecham Pharmaceuticals ("SmithKline"), an international
pharmaceutical company. From March 1982 to March 1994, Mr. Hailey's experience
at SmithKline included managed care sales, marketing, sales management and
hospital sales. For more than three years, he practiced clinical pharmacy in a
teaching hospital. Mr. Hailey holds a Doctor of Pharmacy license.
 
     Ms. Hodges has been the Vice President, Finance of the Company since
November 1994. Ms. Hodges was Director of Taxation and Treasury of the Company
from February 1991 to November 1994. Ms. Hodges is a certified public
accountant.
 
     Ms. Lorenz has been the Vice President, Government Programs of the Company
since March 1995. From January 1994 to March 1995, Ms. Lorenz served as Director
of Government Programs for Sanus Corporate Health Systems (now known as
NYLCare), a managed healthcare company, in Fort Lee, New Jersey, and was
responsible for the nationwide expansion of Medicare and Medicaid risk
contracts. From 1991 to 1993 she served as Medicare Program Coordinator for the
Health Care Financing Administration in New York.
 
     Mr. Mark was named Vice President of the Company and Vice President and
Chief Financial Officer of HealthAmerica Pennsylvania, Inc. on December 16,
1996. From October 1993 to December 1996, Mr. Mark was a partner with Coopers &
Lybrand L.L.P., an international professional services firm. From September 1991
to October 1993, he was a senior manager with the same firm. Mr. Mark is a
certified public accountant.
 
                                      47
<PAGE>   50
 
     Mr. Mayer was named Senior Vice President of the Company and Chief
Operating Officer of HealthAmerica Pennsylvania, Inc. on February 10, 1997. From
November 1994 to February 1997, he was President and Chief Executive Officer of
Independence Financial Services Corp., an insurance holding company located in
Stamford, Connecticut. From February 1989 to November 1994, Mr. Mayer was Senior
Vice President, Chief Financial Officer, Treasurer and a Director of Sierra
Health Services, Inc., a managed care company located in Las Vegas, Nevada which
provides a wide range of services.
 
     Mr. Merkel has been a Regional Vice President of the Company since April
1994. Since October 1995 he has been Chief Executive Officer of HealthAmerica
Pennsylvania, Inc. He was President and Chief Executive Officer of HealthAmerica
of Central Pennsylvania, a division of HealthAmerica Pennsylvania, Inc., from
February 1991 to October 1995.
 
     Mr. Murray has been a Vice President of the Company since December 1995. He
is also Senior Vice President and Chief Marketing Officer of HealthAmerica
Pennsylvania, Inc. He previously served as President, from November 1995 to
March 1997, and as Senior Vice President, Marketing from October 1988 to
November 1995, of HealthAmerica Pennsylvania, Inc.'s Pittsburgh operation.
 
     Ms. Smith has been a Vice President, Corporate General Counsel and
Secretary of the Company since March 1994. From August 1993 to March 1994, she
was Acting General Counsel and Secretary of the Company. From April 1989 to
August 1993, she was Assistant General Counsel of the Company.
 
     Mr. Wolf was elected Senior Vice President, Chief Financial Officer and
Treasurer of the Company on December 9, 1996. From August 1995 to December 1996,
he was Executive Vice President of SpectraScan Health Services, Inc., a
Connecticut women's healthcare services company. From January 1995 to August
1995, Mr. Wolf was Senior Vice President, Business Development for MetraHealth
Companies, Inc., a Connecticut managed healthcare company. Prior to that, from
August 1988 to December 1994, Mr. Wolf was Vice President, Specialty Operations
Officer for the Managed Care and Employee Benefits Operations of The Travelers,
a Hartford, Connecticut insurance company. Mr. Wolf is a Fellow of the Society
of Actuaries.

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
 
     Based solely upon a review of Forms 3, 4 and 5 and amendments thereto
furnished to the Company during fiscal year 1996 pursuant to Rule 16a-3(e) of
the Exchange Act and upon written representations from reporting persons that
Form 5 was not required to report late filings, all reporting persons filed on a
timely basis, except the following: Christopher T. Fey filed one late report
relating to three transactions.

                             ---------------------
 
                                      48
<PAGE>   51
 
Item 11:  Executive Compensation
 
     The following table sets forth annual, long-term and other compensation
awarded to, earned by or paid to the Chief Executive Officer and the persons
who, in fiscal 1996, were the other four most highly compensated executive
officers of the Company (the "Named Executive Officers") for the three fiscal
years ended December 31, 1994, 1995 and 1996:
 
                           SUMMARY COMPENSATION TABLE
 
<TABLE>
<CAPTION>
                                                                         LONG TERM
                                                                       COMPENSATION
                                                                          AWARDS
                                                                      ---------------
                                                ANNUAL COMPENSATION     SECURITIES
                                                -------------------     UNDERLYING       ALL OTHER
NAME AND PRINCIPAL POSITION              YEAR    SALARY     BONUS     OPTIONS/SARS(#)   COMPENSATION
---------------------------              ----   --------   --------   ---------------   ------------
<S>                                      <C>    <C>        <C>        <C>               <C>
Allen F. Wise (1)......................  1996   $137,395   $     --       400,000          $   --
  President & Chief Executive Officer    1995         --         --            --              --
                                         1994         --         --            --              --
Lawrence N. Kugelman(2)................  1996    247,262         --        25,000(3)        6,500(5)
  Director, Former President & Chief     1995     24,167         --         2,000(4)       27,000(6)
  Executive Officer                      1994         --         --         2,000(4)       26,000(6)
Frederick G. Merkel....................  1996    245,607         --       100,000(3)        1,182(5)
  Regional Vice President                1995    219,371         --        25,000           2,910(5)
                                         1994    151,940     67,500        60,000           1,000(5)
Richard H. Jones.......................  1996    229,588         --       100,000(3)        6,750(5)
  Senior Vice President, Finance &       1995    205,000         --        25,000           6,000(5)
  Development                            1994    180,290     64,000            --           6,000(5)
Thomas J. Murray.......................  1996    229,343         --        20,000(3)       11,177(5)
  Vice President                         1995    198,799     12,637        25,000           9,123(5)
                                         1994    134,675     65,900            --           4,587(5)
Christopher T. Fey.....................  1996    220,966         --        25,000(3)           --
  Vice President                         1995    222,819         --       140,000              --
                                         1994    143,162         --            --              --
</TABLE>
 
---------------
 
(1) Allen F. Wise was appointed President and Chief Executive Officer effective
    October 7, 1996.
(2) Lawrence N. Kugelman served as interim President and Chief Executive Officer
    from December 14, 1995 through October 6, 1996.
(3) Does not include options granted in exchange for outstanding options. See
    Report on Repricing of Options, p. 11 of this Proxy Statement.
(4) Options granted under the 1993 Directors Plan.
(5) Consists of employee contributions to the Company's Retirement Savings Plan
    and related nonqualified Supplemental Executive Retirement Plan.
(6) Consists of Outside Director fees.
 
                                      49
<PAGE>   52
 
     The following table provides information on option grants to the Named
Executive Officers during fiscal 1996. No stock appreciation rights ("SARs")
were granted during fiscal 1996.
 
                     OPTION/SAR GRANTS IN LAST FISCAL YEAR
 
<TABLE>
<CAPTION>
                                              INDIVIDUAL GRANTS(1)
                                -------------------------------------------------
                                              PERCENT OF
                                                TOTAL
                                 NUMBER OF     OPTIONS/                             POTENTIAL REALIZABLE VALUE AT
                                SECURITIES       SARS                                  ASSUMED ANNUAL RATES OF
                                UNDERLYING    GRANTED TO   EXERCISE                    STOCK PRICE APPRECIATION
                                 OPTIONS/     EMPLOYEES     OR BASE                        FOR OPTION TERM
                                   SARS       IN FISCAL      PRICE     EXPIRATION   ------------------------------
NAME                            GRANTED(#)       YEAR      ($/SHARE)      DATE           5%               10%
----                            -----------   ----------   ---------   ----------   -------------    -------------
<S>                             <C>           <C>          <C>         <C>          <C>              <C>
Allen F. Wise.................    400,000        35.4%      $11.00      10/07/06       $2,772,000       $6,996,000
Lawrence N. Kugelman..........     25,000         2.2        12.75      03/01/06          200,813          506,813
Frederick G. Merkel...........    100,000         8.8        12.75      09/06/06          803,250        2,027,250
Richard H. Jones..............    100,000         8.8        12.75      09/06/06          803,250        2,027,250
Thomas J. Murray..............     20,000         1.8        12.75      03/01/06          160,650          405,450
Christopher T. Fey............     25,000         2.2        12.75      03/01/06          200,813          506,813
</TABLE>
 
---------------
 
(1) Generally, all options vest in equal increments annually over a four year
    period; Mr. Wise's options vest in equal increments annually over three
    years. Upon a sale or transfer of all or substantially all of the capital
    stock or assets of the Company, or a merger or consolidation with an
    unaffiliated entity, all options will fully vest immediately.
 
     The following table provides information as to options exercised or held
during fiscal 1996 by the Named Executive Officers:
 
              AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR
                          AND FY-END OPTION/SAR VALUES
 
<TABLE>
<CAPTION>
                                                                   NUMBER OF
                                                                   SECURITIES          VALUE OF
                                                                   UNDERLYING        UNEXERCISED
                                                                  UNEXERCISED        IN-THE-MONEY
                                                                OPTIONS/SARS AT    OPTIONS/SARS AT
                                                                FISCAL YEAR-END    FISCAL YEAR-END
                                                                      (#)                ($)
                                     SHARES                     ----------------   ----------------
                                  ACQUIRED ON       VALUE       EXERCISABLE(E)/    EXERCISABLE(E)/
NAME                              EXERCISE (#)   REALIZED ($)   UNEXERCISABLE(U)   UNEXERCISABLE(U)
----                              ------------   ------------   ----------------   ----------------
<S>                               <C>            <C>            <C>                <C>
Allen F. Wise...................          --       $     --              --E            $  --E
                                                                    400,000U               --U
Lawrence N. Kugelman............          --             --          29,000E               --E
                                                                         --U               --U
Frederick G. Merkel.............          --             --          80,168E            8,046E
                                                                    152,500U               --U
Richard H. Jones................          --             --         121,036E            4,321E
                                                                    127,500U               --U
Thomas J. Murray................          --             --          48,584E               --E
                                                                     41,750U               --U
Christopher T. Fey..............          --             --          50,000E               --E
                                                                    115,000U               --U
</TABLE>
 
                                      50
<PAGE>   53
 
                      COMPENSATION AND BENEFITS COMMITTEE
 
                           Laurence DeFrance (Chair)
                              John H. Austin, M.D.
 
DIRECTORS' COMPENSATION
 
     All directors are reimbursed by the Company for out-of-pocket expenses
incurred in connection with attendance at meetings. Members of the Board of
Directors who are not officers or employees of the Company, its subsidiaries or
affiliates ("Outside Directors") each receive an annual retainer of $16,000 paid
in quarterly installments of $4,000 each. Outside Directors also receive $1,000
for each meeting of the Board of Directors or any committee thereof attended,
and $500 for each telephonic meeting.
 
     Pursuant to the 1993 Outside Directors Stock Option Plan, as amended (the
"1993 Directors Plan"), each director who is not an employee of or consultant to
the Company or one of its subsidiaries receives a grant of stock options for
2,000 shares, or 6,000 shares in the case of the Chairman of the Board of
Directors, of the Company's Common Stock on January 1 of each year. Because Dr.
Farley serves as a consultant to Coventry HealthCare Management Corporation, a
subsidiary of the Company, he is eligible to receive options under the Company's
stock option plans for employees and consultants but is not eligible to receive
options under the 1993 Directors Plan. Mr. Kugelman did not receive the stock
option grant on January 1, 1996, because he was employed by the Company as
Interim President and Chief Executive Officer on that date.

EMPLOYMENT CONTRACTS AND TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL
ARRANGEMENTS
 
     Allen F. Wise.  Mr. Wise entered into an Employment Agreement effective
October 7, 1996 for an initial term of one year (the "Initial Term"), which will
continue on a year-to-year basis as long as a new employment contract is not
executed or the agreement has not been otherwise terminated. Under the terms of
the agreement, Mr. Wise receives a base salary of $450,000 per year. In
addition, upon execution of the agreement, Mr. Wise received non-qualified stock
options to purchase 400,000 shares of the Company's Common Stock at an exercise
price of $11.00 per share, the fair market value per share of the Common Stock
as of October 7, 1996. These options will vest over a period of three years,
subject to acceleration in the event that substantially all of the assets or
capital stock of the Company are sold or transferred or the Company is merged or
consolidated with an unaffiliated entity. Mr. Wise is also eligible to receive
an annual incentive bonus of up to 100% of his base salary, determined 50% on
achievement of performance factors by the Company and the remainder to be
granted in the sole discretion of the Compensation and Benefits Committee of the
Board of Directors. If Mr. Wise's employment is terminated by the Company for
any reason other than cause, or he terminates his employment with the Company as
a result of a significant change in the nature or the scope of his position and
authority following a Change in Control (as defined below), the Company will
continue to pay his base salary at that time plus that portion of his annual
incentive bonus which is based on the Company's performance, if those criteria
are met, for a period of twelve months, plus any time period remaining in the
Initial Term. In consideration of these benefits, Mr. Wise agreed not to compete
with the Company during the term of his employment and for one year thereafter.
 
     Christopher T. Fey.  Mr. Fey entered into an Employment Agreement with
HealthCare USA, Inc., effective February 17, 1994, which was amended by an
Amendment dated February 3, 1995, and executed by Mr. Fey, HealthCare USA, Inc.
and the Company. Under the terms of this agreement, Mr. Fey receives a base
salary (currently $220,096 per year) and is also eligible to participate in the
Company's bonus programs available to officers. If Mr. Fey's employment is
terminated by the Company for any reason other than cause, the Company will
continue to pay his base salary at the time for a period of one year following
termination of employment. In consideration of these benefits, Mr. Fey agreed
not to compete with the Company during the term of his employment and for one
year thereafter.
 
     Richard H. Jones.  Mr. Jones entered into an Employment Agreement with the
Company effective November 11, 1996 for an initial term of two years, which will
continue on a year-to-year basis as long as a new employment contract is not
executed or the agreement has not been otherwise terminated. Under the terms of
this agreement, Mr. Jones receives a base salary of $265,000 per year and was
granted non-qualified options to purchase 100,000 shares of the Company's Common
Stock at an exercise price of $12.75 per share, the fair market value per share
of the Common Stock as of September 6, 1996. These options will vest over a
period of four years, subject to acceleration in the event that substantially
all of the assets or capital stock of the Company are sold or transferred or the
Company is merged or consolidated with an unaffiliated entity. Of the options
granted to Mr. Jones under his Employment Agreement, options to purchase 25,000
shares were exchanged for existing nonvested options to purchase the same number
of shares at a higher price. Mr. Jones is eligible to participate in any annual
incentive bonus programs available to officers of the Company and to receive
other incentive compensation as determined annually by the Compensation and
Benefits Committee of the Board of Directors. Additionally, Mr. Jones will be
eligible to receive a retention bonus in the amount of $400,000 to be paid in
full on January 31, 1999, if he is and has been continuously employed with the
Company or a subsidiary of the Company until that time. In the event Mr. Jones
terminates his employment for Good Reason (as defined below), or in the event
the Company terminates his employment for any reason other than cause, Mr. Jones
will continue to receive his yearly base salary for a period of 24 months
following termination and will be allowed to exercise any vested options. In the
event Mr. Jones' employment is terminated at any time within three years
following the occurrence of a Change in Control (as defined below), the terms of
this agreement, except with respect to the exercise and acceleration of options
to purchase Common Stock, will become null and void, and the
 
                                      51
<PAGE>   54
 
terms and conditions of that certain Change in Control Agreement executed by Mr.
Jones and the Company as of September 12, 1995 will control. In consideration of
these benefits, Mr. Jones agreed not to compete with the Company during the term
of his employment and for two years thereafter.
 
     Under the terms and conditions of that Change in Control Agreement, in
exchange for an agreement not to compete with the Company for a period of one
year following the termination of his employment with the Company, Mr. Jones
will receive an amount equal to 299.99% of his base salary plus 299.99% of his
annual bonus if at any time within three years after a Change in Control (as
defined below) his employment is terminated by the Company for any reason other
than cause, or if he terminates his employment with the Company for Good Reason
(as defined below). Under this agreement, benefits are payable as follows: (i)
one-third of the total amount due will be paid in substantially equal
semi-monthly installments over the twelve months immediately following
termination of employment; and (ii) the remaining two-thirds will be paid in a
lump sum within five business days after the expiration of such twelve month
period.
 
     Frederick G. Merkel.  Mr. Merkel entered into an Employment Agreement with
the Company effective September 1, 1996, for an initial term of two years, which
will continue on a year-to-year basis as long as a new employment contract is
not executed or the agreement has not been otherwise terminated. Under the terms
of this Agreement, Mr. Merkel receives a base salary of $265,000 per year, and
was granted options to purchase 100,000 shares of the Company's Common Stock at
an exercise price of $12.75 per share, the fair market value per share of the
Common Stock as of September 6, 1996. These options will vest over a period of
four years, subject to acceleration in the event that substantially all of the
assets or capital stock of the Company are sold or transferred or the Company is
merged or consolidated with an unaffiliated entity. Of the options granted to
Mr. Merkel under his Employment Agreement, options to purchase 25,000 shares
were exchanged for existing nonvested options to purchase the same number of
shares at a higher price. Mr. Merkel is eligible to participate in any annual
incentive bonus programs available to officers of the Company and to receive
other incentive compensation as determined annually by the Compensation and
Benefits Committee of the Board of Directors. Additionally, Mr. Merkel will be
eligible to receive a retention bonus in the amount of $400,000 to be paid in
full on January 31, 1999, if he is and has been continuously employed with the
Company or a subsidiary of the Company until that time. In the event Mr. Merkel
terminates his employment for Good Reason (as defined below), or in the event
the Company terminates his employment for any reason other than cause, Mr.
Merkel will continue to receive his yearly base salary for a period of 24 months
following termination and will be allowed to exercise any vested options. In the
event Mr. Merkel's employment is terminated at any time within three years
following the occurrence of a Change in Control (as defined below), the terms of
this agreement, except with respect to the exercise and acceleration of options
to purchase Common Stock, will become null and void, and the terms and
conditions of that certain Change in Control Agreement executed by Mr. Merkel
and the Company as of September 12, 1995 will control. In consideration of these
benefits, Mr. Merkel agreed not to compete with the Company during the term of
his employment and for two years thereafter.
 
     Under the terms and conditions of that Change in Control Agreement, in
exchange for an agreement not to compete with the Company for a period of one
year following the termination of his employment with the Company, Mr. Merkel
will receive an amount equal to 299.99% of his base salary plus 299.99% of his
annual bonus if at any time within three years after a Change in Control (as
defined below) his employment is terminated by the Company for any reason other
than cause, or he terminates his employment with the Company for Good Reason (as
defined below). Under this agreement, benefits are payable as follows: (i)
one-third of the total amount due will be paid in substantially equal
semi-monthly installments over the twelve months immediately following
termination of employment; and (ii) the remaining two-thirds will be paid in a
lump sum within five business days after the expiration of such twelve month
period.
 
     Thomas J. Murray.  Mr. Murray entered into an Employment Agreement with the
Company effective July 28, 1995, for an initial term of one year, which will
continue on a year-to-year basis as long as a new employment contract is not
executed or the agreement has not been otherwise terminated. Under the terms of
this agreement, Mr. Murray receives a base salary (currently $227,513 per year)
and is also eligible to participate in any annual incentive bonus programs
available to officers of the Company and to receive other incentive compensation
as determined annually by the Compensation and Benefits Committee of the Board
of Directors of the Company. During the term of the Agreement, if Mr. Murray's
employment is terminated for any reason other
 
                                      52
<PAGE>   55
 
than cause, or Mr. Murray terminates his employment for Good Reason (as defined
below), Mr. Murray will continue to receive his yearly base salary for a period
of 12 months following termination. If at any time within two years following
the occurrence of a Change in Control Mr. Murray's employment with the Company
is terminated for any reason other than cause, or he terminates his employment
for Good Reason, Mr. Murray will receive 150% of his base salary and 150% of his
bonus at the time of termination. In consideration of these benefits, Mr. Murray
agreed not to compete with Company during the term of his employment and for a
period of one year thereafter or 18 months thereafter in the case of termination
following a Change in Control.
 
     Definitions.  For purposes of the agreements described above, a "Change in
Control" is defined to include any of the following events: (i) the acquisition
of at least a majority of the outstanding shares of the Company's Common Stock
by any person or entity; (ii) the merger or consolidation of the Company into or
with another entity if, as a result, the persons who owned a majority of the
Common Stock prior to the transaction do not own a majority after the
transaction; (iii) the sale of substantially all of the assets of the Company;
or (iv) any change in the composition of the Board of Directors such that
persons who at the beginning of any period of up to two years constituted at
least a majority of the Board of Directors cease to constitute at least a
majority of the Board of Directors at the end of such period.
 
     For purposes of the agreements described above, "Good Reason" is generally
defined to include a significant change in the nature or scope of the
executive's position and authority or a reduction in base salary. In the Change
in Control Agreements and Mr. Murray's Employment Agreement, "Good Reason" also
includes certain substantial reductions in incentive compensation or a change in
the location in which the executive is required to perform services.
 
     Acceleration of Other Options on a Change in Control.  The Compensation and
Benefits Committee has determined that certain key executive officers who are
granted stock options under the Company's stock option plans will become fully
vested in all options granted to them if, during their employment, substantially
all of the capital stock or assets of the Company are sold or transferred, or if
the Company is merged into or consolidated with another unaffiliated entity.
 
 
                                      53
<PAGE>   56
 

          COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
 
     During the year ended December 31, 1996, the members of the Compensation
and Benefits Committee were Laurence DeFrance (Chair), Emerson D. Farley, Jr.,
M.D. and John H. Austin, M.D. Neither Mr. DeFrance nor Dr. Austin is an officer
or employee or former officer or employee of the Company or any of its
subsidiaries; and neither Mr. DeFrance nor Dr. Austin has any relationship
requiring disclosure by the Company under applicable rules and regulations
promulgated by the Securities and Exchange Commission. As described below, Dr.
Farley serves as a consultant to a subsidiary of the Company. Dr. Farley
resigned from the Compensation and Benefits Committee on December 18, 1996.
After the 1996 annual meeting of shareholders, Dr. Farley did not participate in
decisions of the Compensation and Benefits Committee concerning executive
compensation that would otherwise qualify for the performance-based compensation
exemption from the $1,000,000 limit on the tax deductibility of certain
executive compensation under Section 162(m) of the Internal Revenue Code of
1986, as amended (the "Code").
 
     The Company and Dr. Farley entered into a Consulting Agreement dated
January 1, 1995, under which Dr. Farley provides consulting services to Coventry
HealthCare Management Corporation, the Company's subsidiary headquartered in
Richmond, Virginia, in exchange for a fee of $72,000 per annum. Dr. Farley
served as Chairman of Southern Health Management Corporation, the predecessor of
Coventry HealthCare Management Corporation, prior to its acquisition by the
Company on December 1, 1994. The Consulting Agreement is for a period of one
year renewable annually but may be terminated by either party by giving the
other party 60 days prior written notice of such termination. In addition,
unvested non-qualified options held by Dr. Farley to purchase 5,000 shares of
Common Stock at an exercise price of $24.50 per share and vested non-qualified
options held by Dr. Farley to purchase 7,000 shares of Common Stock at an
exercise price of $24.50 per share were exchanged on September 6, 1996 and
November 6, 1996 for new options to purchase the equivalent number of shares at
the fair market value as of September 6, 1996 of $12.75 per share. The fair
market value of the Company's Common Stock as of November 6, 1996 was $9.625 per
share.

                                      54
<PAGE>   57
Item 12:  Security Ownership of Certain Beneficial Owners and Management
 
     The following table sets forth certain information, as of March 31, 1997,
regarding the beneficial ownership of the Company's Common Stock by (i) each
person or group who is known by the Company to be the beneficial owner of more
than five percent of the Common Stock, (ii) all directors and nominees for
director of the Company, (iii) each executive officer named in the Executive    
Compensation Table and (iv) all directors and executive officers of the Company
as a group. The number of shares beneficially owned by each director or
executive officer is determined under rules promulgated by the Securities and
Exchange Commission, and the information is not necessarily indicative of
beneficial ownership for any other purpose. The Company believes that each of
the beneficial owners of the Common Stock listed below, based on information
furnished by such owner, has sole voting and investment power (or shares such
powers with his or her spouse or in the case of an entity, with its affiliates)
with respect to such shares, subject to the information contained in the notes
to the table.
 
<TABLE>
<CAPTION>
                                                              AMOUNT AND
                                                              NATURE OF      PERCENT
                                                              BENEFICIAL    OF VOTING
NAME AND ADDRESS OF BENEFICIAL OWNER                          OWNERSHIP     STOCK(1)
------------------------------------                          ----------    ---------
<S>                                                           <C>           <C>
Massachusetts Financial Services Company(2).................  3,282,065        9.9%
  500 Boylston Street
  Boston, MA 02116
The Crabbe Huson Group, Inc.(3).............................  2,539,500        7.7%
  121 S.W. Morrison, Suite 1400
  Portland, OR 97204
Neuberger & Berman, LLC(4)..................................  2,509,200        7.6%
  605 Third Avenue
  New York, NY 10158-3698
Philip N. Bredesen..........................................  1,769,276        5.4%
  Office of the Mayor
  107 Metropolitan Courthouse
  Nashville, TN 37201
John H. Austin, M.D.........................................     29,834(5)    *
Laurence DeFrance...........................................     13,334(5)    *
Emerson D. Farley, Jr., M.D.................................     77,510(5)    *
Christopher T. Fey..........................................    510,640(5)     1.6%
Richard H. Jones............................................    121,036(5)    *
Lawrence N. Kugelman........................................     64,000(5)    *
Frederick G. Merkel.........................................     80,688(5)    *
Thomas J. Murray............................................     48,584(5)    *
Allen F. Wise...............................................      2,125       *
Executive Officers and Directors as a Group (19 persons)....  1,046,229(5)     8.6%
</TABLE>
 
---------------
 
 * Less than one percent.
(1) For purposes of this table, a person or group of persons is deemed to
    beneficially own shares issuable upon the exercise of warrants or options
    that are currently exercisable or that will become exercisable within 60
    days from the date set forth above.
(2) According to its most recent Schedule 13G, Massachusetts Financial Services
    Company is a Delaware corporation.
(3) According to its most recent Schedule 13G, the Crabbe Huson Group, Inc. is
    an Oregon corporation.
(4) According to its most recent Schedule 13G, Neuberger & Berman, LLC is a New
    York limited liability company.
(5) Includes the following shares issuable upon exercise of stock options which
    are currently exercisable or which will become exercisable within 60 days of
    the date set forth above: John H. Austin, M.D., 15,334 shares subject to
    options; Laurence DeFrance, 11,334 shares subject to options; Emerson D.
    Farley, Jr., M.D., 17,000 shares subject to options; Christopher T. Fey,
    50,000 shares subject to options; Richard H. Jones, 121,036 shares subject
    to options; Lawrence N. Kugelman, 29,000 shares subject to options;
    Frederick G. Merkel, 80,168 shares subject to options; Thomas J. Murray,
    48,584 shares subject to options; and all executive officers and directors
    as a group (19 persons), 443,168 shares subject to options.

                                      55
<PAGE>   58
Item 13:  Certain Relationships and Related Transactions
 
     The Company and Dr. Emerson D. Farley, Jr. entered into a Consulting
Agreement dated January 1, 1995, under which Dr. Farley provides consulting
services to Coventry Healthcare Management Corporation, the Company's subsidiary
headquartered in Richmond, Virginia, in exchange for a fee of $72,000 per annum.
The Consulting Agreement is for a period of one year renewable annually but may
be terminated by either party by giving the other party 60 days prior written
notice of such termination. In addition, unvested non-qualified options held by
Dr. Farley to purchase 5,000 shares of Common Stock at an exercise price of
$24.50 per share and vested non-qualified options held by Dr. Farley to purchase
7,000 shares of Common Stock at an exercise price of $24.50 per share were
exchanged on September 6, 1996 and November 6, 1996 for new options to purchase
the equivalent number of shares at the fair market value as of September 6, 1996
of $12.75 per share. The fair market value of the Company's Common Stock as of
November 6, 1996 was $9.625 per share.
 
     Christopher T. Fey and his wife, Tamara T. Fey, entered into a revolving
line of credit promissory note (the "Note") on April 15, 1994, in the original
principal amount of $250,000, in favor of HealthCare USA, Inc., headquartered in
Jacksonville, Florida. The Company acquired HealthCare USA, Inc. on July 28,
1995. The maturity date of the Note is the earlier of December 31, 1997 or the
date that Mr. Fey ceases to be employed by HealthCare USA, Inc.


                                      56
<PAGE>   59





                                    PART IV

Item 14:         Exhibits, Financial Statement Schedules and Reports on Form
                 8-K

<TABLE>
<S>     <C>                                                                                                       <C>             
(a) 1.  FINANCIAL STATEMENTS                                                                        

                                                                                                                   Form 10-K
                                                                                                                     Pages
                                                                                                                  ----------
              Report of Independent Public Accountants  . . . . . . . . . . . . . . . . . . . . . . . . . . . .       24

              Consolidated Balance Sheets, December 31, 1996 and 1995 . . . . . . . . . . . . . . . . . . . . .       25  

              Consolidated Statements of Operations for the Years Ended December 31, 1996, 1995 
                and 1994  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       26

              Consolidated Statements of Stockholders' Equity for the Years Ended
                December 31, 1996, 1995 and 1994  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       27

              Consolidated Statements of Cash Flows for the Years Ended December 31, 1996,
                1995 and 1994 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       28

              Notes to Consolidated Financial Statements, December 31, 1996, 1995, and
                 1994 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   29 to 44



    2.  Financial statement schedule        
              Report of Independent Public Accountants  . . . . . . . . . . . . . . . . . . . . . . . . . . . .       S-1

              Schedule II - Valuation and Qualifying Accounts . . . . . . . . . . . . . . . . . . . . . . . . .       S-2

    3.  Exhibits required to be filed by Item 601 of Regulation S-K.
              Exhibits required to be filed by Item 601 of Regulation S-K, whether filed herewith or incorporated
              herein by reference, are listed on the Index to Exhibits of this filing.

(b) 1.  Reports on Form 8-K

              Form 8-K relating to February 24, 1997 press release was
              filed on February 26, 1997.
</TABLE>



                                      57
<PAGE>   60




                                  SIGNATURES


         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed
on its behalf by the undersigned, thereunto duly authorized.


COVENTRY CORPORATION

By:      /s/ Allen F. Wise          President, Chief Executive Officer and 
         -------------------------  Director
             Allen F. Wise



Dated:  April 30, 1997






                                      58
<PAGE>   61




                              ARTHUR ANDERSEN LLP
                              Nashville, Tennessee


                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS

To the Board of Directors and Shareholders of Coventry Corporation:

We have audited, in accordance with generally accepted auditing standards, the
consolidated financial statements of Coventry Corporation and subsidiaries for
the three years ended December 31, 1996 included in the Form 10-K and have
issued our report thereon dated February 21, 1997 (except for Notes G and S, as
to which the date is March 31, 1997).  Our audits were made for the purpose of 
forming an opinion on the basic consolidated financial statements taken as a
whole.  The schedule listed under Item 14(a)(ii) is the responsibility of the
Company's management and is presented for purposes of complying with the
Securities and Exchange Commission's rules and is not part of the basic
consolidated financial statements.  This schedule has been subjected to the
auditing procedures applied in the audit of the basic consolidated financial
statements and, in our opinion, fairly states in all material respects the
financial data required to be set forth herein in relation to the basic
consolidated financial statements taken as a whole.




                                               ARTHUR ANDERSEN LLP


Nashville, Tennessee
February 21, 1997


                                 
                                     S-1


<PAGE>   62




                                                                     SCHEDULE II



                     COVENTRY CORPORATION AND SUBSIDIARIES

                      VALUATION AND QUALIFYING ACCOUNTS
                                (in thousands)

<TABLE>
<CAPTION>                                                                         
                                               Balance at       Additions                                                
                                              Beginning of   Charged to Costs              Deductions         Balance at  
                                                Period        and Expenses (1)          (Charge Offs) (1)    End of Period 
                                              ------------   -----------------          -----------------    -------------
<S>                                             <C>                <C>                       <C>               <C>
Year ended December 31, 1996:
     Allowance for doubtful accounts            $ 2,700            $ 8,000                   $(2,700)          $ 8,000
                                                =======            =======                   =======           =======
Year ended December 31, 1995:
     Allowance for doubtful accounts            $ 2,200            $ 3,100                   $(2,600)          $ 2,700
                                                =======            =======                   =======           =======
Year ended December 31, 1994:
     Allowance for doubtful accounts            $ 1,240            $ 4,100                   $(3,140)          $ 2,200
                                                =======            =======                   =======           =======
</TABLE>

(1) Additions to the allowance for doubtful accounts are included in selling,
    general and administrative expense.  All deductions or charge offs are
    charged against the allowance for doubtful accounts.






                                     S-2
<PAGE>   63




                               INDEX TO EXHIBITS

Reg. S-K
Item 601

Exhibit
No.      Description of Exhibit


(2)      Plan of Acquisition, Reorganization, Arrangement, Liquidation or
         Succession:

         (i)
         Agreement and Plan of Merger dated February 3, 1995 among the Company,
         Coventry Acquisition Corporation and HealthCare USA, Inc.
         (Incorporated by reference to Exhibit 2.1 to Form S-4 on Form S-3,
         Registration Statement Nos. 33-90268 and 33-95084)

         (ii)
         Stock Purchase and Sale Agreement dated as of October 31, 1994 between
         the Company and Presbyterian University Hospital. (Incorporated by
         reference to Exhibit 2.1 to Form 8-K dated October 31, 1994 and filed
         with the SEC on November 2, 1994)

         (iii)
         Stock Purchase and Merger Agreement by and among AHP Holdings, Inc.,
         PARTNERS Health Plan of Pennsylvania, Inc., the Company and Coventry
         Acquisition Corporation dated as of December 18, 1995 (Incorporated by
         reference to Exhibit 2.2 to Annual Report on Form 10-K for the year
         ended December 31, 1995) and Amendment No. 1 thereto dated March 20,
         1996 (Incorporated by reference to Exhibit 2(ii) to the PARTNERS
         Health Plan of Pennsylvania, Inc. Current Report on Form 8-K dated
         March 20, 1996).

(3)      Articles of Incorporation and Bylaws:

         (i)
         Fifth Restated Certificate of Incorporation of Coventry Corporation
         (Incorporated by reference to Exhibit 3.1 attached to Annual Report on
         Form 10-K for fiscal year ended December 31, 1994)

         (ii)
         Bylaws of Coventry Corporation (Incorporated by reference to Exhibit
         3.2 to Form S-1, Registration Statement No. 33-36616), Amendment No. 1
         (Incorporated by reference to Exhibit 3.2.1 attached to Annual Report
         on Form 10-K for fiscal year ended December 31, 1994), and Amendment
         No. 2 (See Exhibit 3.2.2 attached to the Annual Report on Form 10-K
         for the year ended December 31, 1995).

(4)      Instruments Defining the Rights of Security Holders, Including
         Indentures:

         (i)
         Specimen Common Stock Certificate (See Exhibit 4.1 attached to the
         Annual Report on Form 10-K for the year ended December 31, 1995 and
         the Company's Certificate of Incorporation referenced at (3)(i) above)

         (ii)
         See Second Amended and Restated Credit Agreement referenced at 10(i) 
         below and the amendments thereto referenced at 10(i), 10(xx) and
         10(xxi) below.

         (iii)
         Shareholder Rights Agreement dated February 7, 1996 between the
         Company and Chemical Mellon Shareholder Services, L.L.C. (Incorporated
         by reference to Exhibit 4 to Form 8-K, Current Report, dated February
         7, 1996)
<PAGE>   64




(10)     Material Contracts

         (i)
         Second Amended and Restated Credit Agreement dated as of November 20,
         1992 among the Company, Morgan Guaranty Trust Company of New York,
         Fleet National Bank, Third National Bank in Nashville, NationsBank of
         Tennessee, N.A., Citicorp USA, Inc., Mellon Bank, N.A., First American
         National Bank, and Morgan Guaranty Trust Company of New York as Agent
         ($125,000,000 Credit Facility) (See Exhibit 10.6 attached to the
         Annual Report on Form 10-K for the year ended December 31, 1995) and
         related documents (Incorporated by reference to Exhibit 10.6 attached
         to Annual Report on Form 10-K for fiscal year ended December 31,
         1994), Amendment No. 1 (See Exhibit 10.6.1 attached to the Annual
         Report on Form 10-K for the year ended December 31, 1995) and
         Amendment No. 2 (See Exhibit 10.6.2 attached to the Annual Report on
         Form 10-K for the year ended December 31, 1995)

         (ii)
         Amended and Restated Employment Agreement dated December 1, 1994,
         between Southern Health Management Corporation, the Company and James
         L. Gore (Incorporated by reference to Exhibit 10.7.7 attached to
         Annual Report on Form 10-K for fiscal year ended December 31, 1994)*

         (iii)
         Employment Agreement dated February 17, 1994 between HealthCare USA,
         Inc. and Christopher T. Fey, as amended by Amendment to Employment
         Agreement dated February 3, 1995 between HealthCare USA, Inc., the
         Company and Mr. Fey (effective as to the Company on July 28, 1995)
         (Incorporated by reference to Exhibit (xxv) to Form 10-Q, Quarterly
         Report, for the quarter ended September 30, 1995)*

         (iv)
         Employment Agreement dated September 16, 1996 executed by 
         Allen F. Wise** 

         (v)
         Employment Agreement dated December 30, 1996 executed by Dale B.
         Wolf**

         (vi)
         Form of Company's Agreement (for Key Senior Executives) dated
         September 12, 1995 (executed by Richard H. Jones and Frederick G.
         Merkel) (Incorporated by reference to Exhibit (xxviii) to Form 10-Q,
         Quarterly Report, for the quarter ended September 30, 1995)*

         (vii)
         Form of Company's Agreement (for Key Executives) dated September 12,
         1995 (executed by James R. Hailey, Jan H.  Hodges, Nancy I. Lorenz and
         Shirley R. Smith) (Incorporated by reference to Exhibit (xxix) to Form
         10-Q, Quarterly Report, for the quarter ended September 30, 1995)*

         (viii)
         Employment Agreement dated as of July 28, 1995, between Thomas Murray,
         HealthAmerica Pennsylvania, Inc. and the Company (See Exhibit 10.7.1
         attached to the Annual Report on Form 10-K for the year ended December
         31, 1995)*

         (ix)
         Second Amended and Restated 1987 Statutory-Nonstatutory Stock Option
         Plan (Incorporated by reference to Exhibit 10.8.1 attached to Annual
         Report on Form 10-K for fiscal year ended December 31, 1993)*
         
<PAGE>   65




         (x)
         Third Amended and Restated 1989 Stock Option Plan (Incorporated by
         reference to Exhibit 10.8.2 attached to Annual Report on Form 10-K for
         fiscal year ended December 31, 1993)*

         (xi)
         1993 Outside Directors Stock Option Plan (as amended)(See Exhibit
         10.8.3 attached to the Annual Report on Form 10-K for the year ended
         December 31, 1995)*

         (xii)
         1993 Stock Option Plan (as amended)(See Exhibit 10.8.4 attached to the
         Annual Report on Form 10-K for the year ended December 31, 1995)*

         (xiii)
         Coventry Corporation Supplemental Executive Retirement Plan effective
         July 1, 1994 (Incorporated by reference to Exhibit 4.2 to Form S-8,
         Registration Statement No. 33-81358)*

         (xiv)
         Coventry Share Plan (stock purchase plan) effective September 1, 1994
         (Incorporated by reference to Exhibit 4.1 to Form S-8, Registration
         Statement No. 33-82562)*

         (xv)
         Southern Health Management Corporation 1993 Stock Option Plan (See
         Exhibit 10.8.5 attached to the Annual Report on Form 10-K for the year
         ended December 31, 1995)*

         (xvi)
         Coinsurance Agreement effective January 1, 1995, between American
         Service Life Insurance Company (now known as Coventry Health and Life
         Insurance Company) and Mid-West National Life Insurance Company of
         Tennessee (See Exhibit 10.9.1 attached to the Annual Report on Form
         10-K for the year ended December 31, 1995)

         (xvii)
         Assumption Reinsurance Agreement between American Service Life
         Insurance Company (now known as Coventry Health and Life Insurance
         Company) and Mid-West National Life Insurance Company of Tennessee
         (See Exhibit 10.9.2 attached to the Annual Report on Form 10-K for the
         year ended December 31, 1995)

         (xviii)
         Subordinated Promissory Surplus Note dated May 12, 1995 in the amount
         of $2,797,445 from HealthCare USA of Missouri, L.L.C. to the Company
         (See Exhibit 10.9.3 attached to the Annual Report on Form 10-K for the
         year ended December 31, 1995)

         (xix)
         License Agreement dated as of December 31, 1992 between Maxicare
         Health Plans, Inc. and the Company (Incorporated by reference to
         Exhibit 10.18.1 attached to Annual Report in Form 10-K for fiscal year
         ended December 31, 1993) and Amendment No. 1 to License Agreement
         between Maxicare Health Plans, Inc. and the Company (Incorporated by
         reference to Exhibit 10.18.2 attached to Annual Report on Form 10-K
         for fiscal year ended December 31, 1993)

         (xx)
         Amendment No. 3 to the Second Amended and Restated Credit
         Agreement, dated as of September 30, 1996, among the Company, the Banks
         listed on the signature pages thereof and Morgan Guaranty Trust Company
         of New York as Agent (See Exhibit 10.6.3 attached to the Annual Report
         on Form 10-K for the year ended December 31, 1996).**

         (xxi)
         Amendment No. 4 to the Second Amended and Restated Credit
         Agreement, dated as of January 10, 1997, among the Company, the Banks
         listed on the signature pages thereof and Morgan Guaranty Trust
         Company of New York as Agent (See Exhibit 10.6.4) attached to the
         Annual Report on Form 10-K for the year ended December 31, 1996.**

         (xxii)
         Employment Agreement dated October 14, 1996 executed by Joe Carroll**

         (xxiii)
         Employment Agreement dated January 1, 1997 executed by Jan H. Hodges**

         (xxiv)
         Employment Agreement dated November 11, 1996 executed by Richard H.
         Jones**

         (xxv)
         Employment Agreement dated January 15, 1997 executed by Nancy I.
         Lorenz**

         (xxvi)
         Employment Agreement dated January 27, 1997 executed by George R.
         Mark**

         (xxvii)
         Employment Agreement dated January 24, 1997 executed by Robert A.
         Mayer**

         (xxviii)
         Employment Agreement dated February 10, 1996 executed by Frederick G.
         Merkel**

         (xxix)
         Employment Agreement dated January 15, 1997 executed by Shirley R.
         Smith**

         (xxx)
         Retention Bonus Agreement dated December 31, 1996, executed by James
         L. Gore**
   
(11)     Statement re Computation of Per Share Earnings

         (i)
         Computation of Net Earnings Per Common and Common Equivalent Share
         (See Exhibit 11 attached to this Report).
        
(21)     Subsidiaries of the Registrant

         (i)
         Subsidiaries of the Registrant (See Exhibit 21 attached to this Report)

(23)     Consents of Experts and Counsel

         (i)
         Consent of Arthur Andersen LLP (See Exhibit 23 attached to this Report)

         All other exhibits for which provision is made in Item 601 of
Regulation S-K promulgated by the Securities and Exchange Commission are either
not required by the instructions to Item 601 or are inapplicable and,
therefore, have been omitted.

 *       Management contract or compensatory plan.

**       Previously filed as part of Annual Report on Form 10-K for fiscal year
         ended December 31, 1996.

(27)     Financial Data Schedule